{"gene":"MCPH1","run_date":"2026-06-10T02:59:50","timeline":{"discoveries":[{"year":2005,"finding":"BRIT1/MCPH1 is required for activation of both intra-S and G2/M checkpoints in response to ionizing radiation; depletion of BRIT1 abolishes IR-induced cell cycle arrest and reduces expression of BRCA1 and Chk1, and phosphorylation of Nbs1, placing BRIT1 upstream of BRCA1-Chk1 in the DNA damage response pathway.","method":"siRNA depletion in human cells, cell cycle checkpoint assays (flow cytometry), Western blot, immunofluorescence co-localization with γ-H2AX foci","journal":"Proceedings of the National Academy of Sciences of the United States of America","confidence":"High","confidence_rationale":"Tier 2 / Strong — multiple orthogonal methods (checkpoint assay, Western blot, foci co-localization), independently replicated and confirmed by follow-up replication study (PMID:bio_10.1101_2025.06.19.660578)","pmids":["16217032","bio_10.1101_2025.06.19.660578"],"is_preprint":false},{"year":2006,"finding":"BRIT1 forms IR-induced nuclear foci within minutes of irradiation and co-localizes with 53BP1, MDC1, NBS1, ATM, RPA, and ATR; BRIT1 depletion impairs activation of these DDR elements, identifying BRIT1 as a proximal factor in ATM/ATR pathways and its loss increases chromosomal aberrations.","method":"Immunofluorescence foci analysis, co-localization studies, siRNA knockdown, chromosomal aberration assays","journal":"Cancer cell","confidence":"High","confidence_rationale":"Tier 2 / Strong — multiple orthogonal methods (foci analysis, co-localization, chromosomal aberration assays), consistent with findings from independent labs","pmids":["16872911"],"is_preprint":false},{"year":2007,"finding":"MCPH1 localizes to sites of DNA double-strand breaks via its C-terminal tandem BRCT domains, which bind phospho-H2AX (γH2AX) in vitro; this localization depends on H2AX phosphorylation but is independent of MDC1. Overexpression of wild-type but not C-BRCT mutant MCPH1 interferes with MDC1 and 53BP1 foci formation.","method":"BRCT domain deletion/mutation constructs, co-immunoprecipitation, in vitro peptide binding assay, immunofluorescence in H2AX-deficient and MDC1-depleted cells","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 2 / Strong — domain mapping with mutagenesis, in vitro binding, multiple cell line validations, replicated by structural studies","pmids":["17925396"],"is_preprint":false},{"year":2007,"finding":"MCPH1's C-terminal tandem BRCT domains (BRCT2+BRCT3) are required for ionizing radiation-induced nuclear focus (IRIF) formation, while the N-terminal BRCT1 domain is required for centrosomal localization in irradiated cells. Centrosomal targeting is independent of ATM, Brca1, and Chk1 but IRIF formation requires H2AX.","method":"Domain deletion constructs, immunofluorescence in ATM-deficient, Brca1-deficient, and H2AX-deficient cell lines (chicken DT40 system)","journal":"Oncogene","confidence":"High","confidence_rationale":"Tier 2 / Strong — multiple domain mutants tested across multiple genetic backgrounds with orthogonal methods","pmids":["17599047"],"is_preprint":false},{"year":2008,"finding":"BRIT1/MCPH1 increases its interaction with the SWI-SNF chromatin remodeling complex (via the BAF170 subunit) after DNA damage in an ATM/ATR-dependent phosphorylation-dependent manner, recruiting SWI-SNF to DNA lesions to promote chromatin relaxation and facilitate repair factor recruitment.","method":"Co-immunoprecipitation, chromatin fractionation, siRNA knockdown, chromatin accessibility assay (micrococcal nuclease sensitivity), ATM/ATR inhibition","journal":"Nature cell biology","confidence":"High","confidence_rationale":"Tier 2 / Strong — multiple orthogonal methods (Co-IP, chromatin fractionation, accessibility assay), mechanistically defined pathway","pmids":["19525936"],"is_preprint":false},{"year":2008,"finding":"MCPH1 physically interacts with Condensin II via its CAPG2 subunit, through MCPH1's middle domain (residues 376–485). Condensin II depletion causes defects in homologous recombination (HR) repair similar to those in MCPH1-null MEFs, and the Condensin II-binding region of MCPH1 is required for HR function.","method":"Co-immunoprecipitation, domain mapping, siRNA knockdown, HR repair assay (DR-GFP reporter), MCPH1-null MEFs","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 2 / Strong — reciprocal Co-IP, domain mapping, functional rescue assay, genetic validation in knockout MEFs","pmids":["18718915"],"is_preprint":false},{"year":2008,"finding":"MCPH1 cooperates with E2F1 to regulate transcription of CHK1, BRCA1, RAD51, DDB2, TOPBP1, p73, and caspases by physically interacting with E2F1 on their promoters. MCPH1 forms oligomers via its second and third BRCT domains; a dominant-negative oligomerization domain mutant blocks MCPH1-E2F1 interaction and inhibits p73 induction and E2F1-dependent apoptosis.","method":"Co-immunoprecipitation, chromatin immunoprecipitation (ChIP), reporter gene assays, siRNA knockdown, dominant-negative mutant overexpression, apoptosis assays","journal":"EMBO reports","confidence":"High","confidence_rationale":"Tier 2 / Strong — ChIP, Co-IP, and functional assays with dominant-negative mutant, multiple target genes tested","pmids":["18660752"],"is_preprint":false},{"year":2009,"finding":"The X-ray crystal structure of the human MCPH1 N-terminal BRCT domain (Mcph1N) at 1.6 Å resolution reveals an elongated β1-α1 loop and a hydrophobic pocket in the equivalent position of phosphate-binding sites. Mutations in this pocket abrogate MCPH1's ability to rescue the premature chromosome condensation (PCC) phenotype in Mcph1−/− MEFs, indicating this pocket forms a protein-protein interaction site required to prevent PCC.","method":"X-ray crystallography, site-directed mutagenesis, complementation assay in Mcph1−/− MEFs (PCC phenotype rescue)","journal":"Journal of molecular biology","confidence":"High","confidence_rationale":"Tier 1 / Strong — crystal structure with functional mutagenesis and cellular rescue assay, rigorous mechanistic validation","pmids":["19925808"],"is_preprint":false},{"year":2010,"finding":"In MCPH1-deficient patient cells, siRNA-mediated depletion of Condensin II subunits (but not Condensin I) reverses premature chromosome condensation in G1 and G2, demonstrating that Condensin II activity is required for the PCC phenotype caused by MCPH1 deficiency. Condensin I remains cytoplasmic in prophase-like MCPH1-deficient cells.","method":"siRNA knockdown of Condensin I/II subunits in MCPH1 patient cells, cell cycle staging by FACS and microscopy, subcellular fractionation","journal":"Cell cycle (Georgetown, Tex.)","confidence":"High","confidence_rationale":"Tier 2 / Strong — epistasis via selective subunit depletion, confirmed in both patient cells and HeLa cells","pmids":["16434882"],"is_preprint":false},{"year":2010,"finding":"BRIT1/MCPH1 knockout mice are hypersensitive to γ-irradiation, exhibit severe chromatid breaks, reduced RAD51 foci formation after IR, and infertility due to impaired meiotic homologous recombination. BRIT1 binds RAD51/BRCA2 complexes and its absence reduces recruitment of RAD51 and BRCA2 to chromatin at damage sites without altering their protein levels.","method":"BRIT1 knockout mouse model, γ-irradiation sensitivity assays, immunofluorescence for RAD51 foci, meiotic chromosome spread analysis, co-immunoprecipitation (BRIT1-RAD51/BRCA2 interaction), chromatin fractionation","journal":"PLoS genetics","confidence":"High","confidence_rationale":"Tier 2 / Strong — knockout mouse with multiple orthogonal in vivo and in vitro methods, Co-IP, chromatin fractionation","pmids":["20107607"],"is_preprint":false},{"year":2011,"finding":"MCPH1 disruption in mice causes primary microcephaly through premature switching of neuroprogenitors from symmetric to asymmetric division. Mechanistically, MCPH1 deficiency abrogates Chk1 localization to centrosomes, causing premature Cdk1 activation and early mitotic entry, uncoupling the centrosome cycle from mitosis. Silencing of Cdc25b (a centrosomal Chk1 substrate) rescues spindle misalignment and premature neurogenesis in Mcph1-knockout neocortex.","method":"Mcph1 knockout mouse model, immunofluorescence for Chk1 at centrosomes, Cdk1 activity assay, spindle orientation analysis, Cdc25b siRNA in vivo rescue, clonal analysis of neuroprogenitor division mode","journal":"Nature cell biology","confidence":"High","confidence_rationale":"Tier 2 / Strong — in vivo genetic rescue (Cdc25b silencing) plus multiple cellular readouts in knockout model, epistasis established","pmids":["21947081"],"is_preprint":false},{"year":2011,"finding":"hMCPH1's N-terminal domain specifically inhibits Condensin II by competing for its chromosomal binding sites in a Xenopus egg extract cell-free assay. The N-terminal domain alone is sufficient to rescue the PCC phenotype in patient cells; the central domain plays an auxiliary role in chromosome shaping by physically interacting with Condensin II.","method":"Xenopus egg extract cell-free chromosome condensation assay, domain deletion constructs, complementation assay in MCPH1 patient cells, co-immunoprecipitation","journal":"The Journal of cell biology","confidence":"High","confidence_rationale":"Tier 1 / Strong — cell-free reconstitution assay combined with domain mapping and patient cell complementation","pmids":["21911480"],"is_preprint":false},{"year":2011,"finding":"SET nuclear oncogene is a direct binding partner of the MCPH1 N-terminal BRCT domain. SET knockdown causes abnormal chromosome condensation that is rescued by Condensin II knockdown. MCPH1 missense mutations (V50G/I51V) that impair SET binding fail to fully rescue chromosome condensation in Mcph1−/− MEFs.","method":"Co-immunoprecipitation, siRNA knockdown, complementation assay in Mcph1−/− MEFs, missense mutagenesis","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 2 / Strong — Co-IP, epistasis via double knockdown, functional rescue with separation-of-function mutant","pmids":["21515671"],"is_preprint":false},{"year":2011,"finding":"MCPH1 C-terminal tandem BRCT domains bind phospho-Cdc27 (a component of APC/C) in a phosphorylation-dependent manner. The crystal structure of MCPH1 C-BRCTs in complex with a phosphorylated Cdc27 peptide was determined, and structure-guided mutations disrupted the interaction in vitro and in cells.","method":"X-ray crystallography of C-BRCT–pCdc27 peptide complex, in vitro binding assays, co-immunoprecipitation, structure-guided mutagenesis","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1 / Strong — crystal structure with in vitro binding and mutagenesis, multiple orthogonal methods","pmids":["22139841"],"is_preprint":false},{"year":2011,"finding":"Crystal structures of MCPH1 C-terminal tandem BRCT domains (alone and in complex with γH2AX tail) reveal a phosphopeptide binding pocket distinct from other BRCT domains; fluorescence polarization assays show selectivity for pSer+3 and preference for phosphopeptide with free COOH-terminus.","method":"X-ray crystallography, fluorescence polarization binding assay","journal":"Journal of structural biology","confidence":"High","confidence_rationale":"Tier 1 / Strong — crystal structure with biochemical binding assay, dual structural validation","pmids":["22154951"],"is_preprint":false},{"year":2012,"finding":"MCPH1 tandem BRCT domains can read both pSer139 (monophosphorylated) and the diphosphorylated (pSer139/pTyr142) states of H2A.X. Structural, biochemical, and cellular evidence show that MCPH1 recruitment to DNA damage sites is linked to both H2A.X phosphorylation states, making MCPH1 a dual sensor of H2A.X marks.","method":"X-ray crystallography (structural analysis), biochemical binding assays, cellular recruitment assays (immunofluorescence), mutagenesis","journal":"Proceedings of the National Academy of Sciences of the United States of America","confidence":"High","confidence_rationale":"Tier 1 / Strong — crystal structure combined with biochemical and cellular validation, multiple orthogonal methods","pmids":["22908299"],"is_preprint":false},{"year":2015,"finding":"BRIT1/MCPH1 is K63-ubiquitinated in unstimulated cells, and deubiquitination by USP8 is a prerequisite for BRIT1 recruitment to DSB sites via γH2AX. BRUCE acts as a scaffold bridging USP8 and BRIT1 to coordinate USP8-catalyzed deubiquitination. Loss of BRUCE or USP8 impairs BRIT1 deubiquitination, its binding to γH2AX, and chromatin relaxation.","method":"Ubiquitination assays (K63 linkage), co-immunoprecipitation (BRUCE-USP8-BRIT1 complex), siRNA knockdown, immunofluorescence foci assay, HR repair assay, BRUCE mutant mice","journal":"Proceedings of the National Academy of Sciences of the United States of America","confidence":"High","confidence_rationale":"Tier 2 / Strong — biochemical ubiquitination assay, trimeric complex Co-IP, in vivo mouse model validation, multiple orthogonal methods","pmids":["25733871"],"is_preprint":false},{"year":2017,"finding":"MCPH1 interacts with βTrCP2 E3 ligase and promotes degradation of Cdc25A independent of DNA damage, thereby regulating G2/M mitotic entry. MCPH1 itself is degraded by APC/C-Cdh1 (not APC/C-Cdc20) in late mitosis/G1. Overexpression of βTrCP2 or knockdown of Cdc25A rescues premature differentiation of Mcph1-deficient neuroprogenitors in vivo.","method":"Co-immunoprecipitation (MCPH1-βTrCP2), protein degradation assays, in utero electroporation (siRNA/overexpression), immunofluorescence, APC/C substrate assays","journal":"The EMBO journal","confidence":"High","confidence_rationale":"Tier 2 / Strong — Co-IP, in vivo genetic rescue, multiple degradation assays, epistasis established","pmids":["29150431"],"is_preprint":false},{"year":2017,"finding":"BRIT1/MCPH1 is recruited to the Ig heavy chain (Igh) locus in an activation-induced cytidine deaminase (AID)- and H2AX-dependent manner. Conditional deletion of BRIT1 in B cells leads to increased unrepaired Igh breaks and reduced class switch recombination (CSR). The C-terminal BRCT domains facilitate interaction with phospho-H2AX, and BRIT1 depletion worsens CSR defects when combined with MDC1 depletion.","method":"Conditional knockout mouse model, ChIP at Igh locus, CSR assays (FACS for IgG subclasses), co-immunoprecipitation, shRNA screen, double knockdown","journal":"Proceedings of the National Academy of Sciences of the United States of America","confidence":"High","confidence_rationale":"Tier 2 / Strong — conditional knockout mouse, ChIP, functional CSR assay, epistasis with MDC1","pmids":["28724724"],"is_preprint":false},{"year":2020,"finding":"MCPH1 directly binds to single-stranded DNA and directly interacts with RAD51 at multiple contact points. MCPH1 enhances stability of RAD51-ssDNA filaments approximately 2-fold (single-molecule tethered particle motion), providing a biochemical mechanism for MCPH1's role in HR repair.","method":"Purified recombinant MCPH1 protein from mammalian expression system, DNA binding assays, co-immunoprecipitation with RAD51, single-molecule tethered particle motion analysis of RAD51-ssDNA filament lifetime","journal":"Nucleic acids research","confidence":"High","confidence_rationale":"Tier 1 / Strong — reconstitution with purified proteins, single-molecule analysis, multiple interaction mapping experiments","pmids":["32735676"],"is_preprint":false},{"year":2020,"finding":"MCPH1 specifically interacts with the TRFH domain of TRF2 via its 330YRLSP334 motif, as revealed by crystal structure. TRF2-dependent recruitment of MCPH1 promotes localization of DNA damage factors and homology-directed repair at dysfunctional telomeres lacking POT1-TPP1, and MCPH1 promotes telomere replication fork progression and restart of stalled forks.","method":"Crystal structure of MCPH1-TRF2 complex, co-immunoprecipitation, immunofluorescence at telomeres (TIF assay), replication fork assay (DNA fiber), telomere replication stress assays","journal":"Nature communications","confidence":"High","confidence_rationale":"Tier 1 / Strong — crystal structure, functional cellular assays, multiple orthogonal methods","pmids":["33203878"],"is_preprint":false},{"year":2021,"finding":"MCPH1 inhibits Condensin II during interphase by binding to the NCAPG2 subunit of Condensin II via a short linear motif. Deletion of Mcph1 in mouse ESCs unleashes Condensin II to form compact chromosomes in G1 and G2 phases even without CDK1 activity, with enhanced A/B compartment mixing. MCPH1's ability to block Condensin II chromatin association is abrogated by fusion of SMC2 with NCAPH2, analogous to cohesin regulation by WAPL.","method":"Mcph1 knockout mouse ESCs, Hi-C chromatin architecture analysis, CDK1 inhibition experiments, SMC2-NCAPH2 fusion construct, co-immunoprecipitation, fluorescence microscopy","journal":"eLife","confidence":"High","confidence_rationale":"Tier 2 / Strong — genetic knockout, structural (Hi-C), biochemical (Co-IP), epistasis with SMC2-NCAPH2 fusion, CDK1 independence established","pmids":["34850681"],"is_preprint":false},{"year":2021,"finding":"The N-terminal BRCT domain of MCPH1 is essential for brain size determination, gonad development, DNA damage response, and prevention of premature chromosome condensation (PCC) in vivo. Mouse model lacking only the N-BRCT domain (Mcph1-ΔBR1) recapitulates all phenotypes of complete Mcph1 knockout, including microcephaly, infertility, and PCC.","method":"Mouse model (Mcph1-ΔBR1 deletion), brain size measurement, fertility assays, MEF DNA damage response assays, chromosome condensation analysis (PCC phenotype)","journal":"Cell death & disease","confidence":"High","confidence_rationale":"Tier 2 / Strong — domain-specific in vivo mouse model with comprehensive phenotypic and cellular analysis","pmids":["33542216"],"is_preprint":false},{"year":2013,"finding":"Deletion of Mcph1 results in a specific reduction of cerebral cortex at birth with premature neurogenic production causing excess early-born deep-layer neurons (IV-VI) and fewer late-born upper-layer neurons (II-III), without affecting neuronal migration. Mcph1 deletion also compromises homologous recombination repair and increases genomic instability. IR causes massive apoptosis in Mcph1-null neocortex.","method":"Mcph1 knockout mouse model, BrdU/EdU birth-dating of cortical layers, HR repair assay (RAD51 foci, comet assay), γ-irradiation survival, TUNEL apoptosis assay","journal":"DNA repair","confidence":"High","confidence_rationale":"Tier 2 / Strong — knockout mouse model with layer-specific birth-dating, multiple HR assays","pmids":["23683352"],"is_preprint":false},{"year":2014,"finding":"BRIT1 regulates p53 protein stability post-transcriptionally by blocking MDM2-mediated p53 ubiquitination. BRIT1 knockdown in normal breast epithelial cells causes oncogenic transformation. BRIT1 overexpression suppresses breast cancer cell proliferation in vitro and tumor growth in vivo.","method":"Co-immunoprecipitation (BRIT1-MDM2-p53), ubiquitination assay, BRIT1 knockdown in MCF10A cells (transformation assay), soft agar colony formation, xenograft tumor model","journal":"Carcinogenesis","confidence":"High","confidence_rationale":"Tier 2 / Strong — biochemical ubiquitination mechanism, multiple functional assays in vitro and in vivo","pmids":["23729656"],"is_preprint":false},{"year":2014,"finding":"BRIT1 phosphorylation at Ser-322 by ATM or ATR in response to replication stress facilitates recruitment of TopBP1 (a key ATR activator) to DNA damage sites, amplifying ATR signaling. BRIT1 is dispensable for ATR initiation but required for amplification of ATR-dependent signaling.","method":"Co-immunoprecipitation (BRIT1-TopBP1), phospho-specific antibody for pSer-322, siRNA knockdown, ChIP at damage sites, ATR signaling assays","journal":"The Journal of biological chemistry","confidence":"Medium","confidence_rationale":"Tier 2 / Weak — Co-IP and phospho-site mapping in single lab, mechanistically defined but not yet independently replicated","pmids":["25301947"],"is_preprint":false},{"year":2018,"finding":"Both MCPH1 isoforms are phosphorylated in a CDK1-dependent manner during mitosis. Upon mitotic exit, both isoforms are degraded by APC/C-Cdh1 E3 ligase; the long isoform via a D-Box degron and the short isoform via a KEN-Box degron, demonstrating isoform-specific degradation mechanisms.","method":"Cell cycle synchronization, phospho-proteomics/site identification, co-immunoprecipitation with APC/C components, proteasome inhibitor experiments, D-box and KEN-box mutagenesis","journal":"FASEB journal : official publication of the Federation of American Societies for Experimental Biology","confidence":"Medium","confidence_rationale":"Tier 2 / Weak — multiple methods (synchronization, mutagenesis, Co-IP) but single lab","pmids":["30303738"],"is_preprint":false},{"year":2020,"finding":"Mcph1 is expressed at mitochondria in apical radial glial cells and controls their proliferation/survival potentially through interactions with VDAC1/GRP75 and AKT/HK2/VDAC1 (mitochondrial activity) and ATF4/PCK2 (glutaminolysis) pathways.","method":"Immunofluorescence co-localization (MCPH1 and mitochondrial markers), Mcph1 knockout mouse cortex, transcriptomic analysis, Western blot for pathway components","journal":"Cell reports","confidence":"Low","confidence_rationale":"Tier 3 / Weak — co-localization and knockout transcriptomics, mechanistic link to metabolic pathways is correlative without direct biochemical interaction validation","pmids":["32294449"],"is_preprint":false},{"year":2024,"finding":"In hematopoietic stem cells, MCPH1 is present in both nucleus (maintaining genomic stability) and cytoplasm (preventing necroptosis by binding phospho-RIPK3). Aging triggers KAT7-mediated acetylation of the MCPH1 NLS motif, promoting nuclear translocation, reducing cytoplasmic MCPH1, and activating RIPK3-dependent necroptosis and HSC deterioration.","method":"Subcellular fractionation, co-immunoprecipitation (MCPH1-p-RIPK3), acetylation mapping, KAT7 inhibition/knockdown, NLS acetylation site mutagenesis, HSC functional assays (transplantation), necroptosis inhibitor rescue","journal":"Nature aging","confidence":"High","confidence_rationale":"Tier 2 / Strong — Co-IP with p-RIPK3, acetyltransferase identification, NLS mutagenesis, functional HSC assays, mechanistic epistasis established","pmids":["38632351"],"is_preprint":false},{"year":2024,"finding":"Mcph1 knockout in mice leads to p19ARF upregulation in MEFs, causing CDK-inhibitor p21-dependent cell cycle arrest and cellular senescence. Silencing p19Arf rescues cell cycle and growth arrest to wild-type levels. p53 pathway activation in Mcph1-deficient erythroid precursors leads to Cdkn1a/p21 overexpression. However, p53 inactivation does not reverse anemia or microcephaly in Mcph1-null mice, suggesting p53 activation is a consequence rather than a cause of the proliferation defect.","method":"Mcph1 knockout mouse/MEF model, RNA-seq transcriptomics, p19Arf siRNA rescue, cell cycle assays, Mcph1/p53 double-knockout analysis","journal":"International journal of molecular sciences / EMBO reports","confidence":"Medium","confidence_rationale":"Tier 2 / Weak — genetic rescue via p19Arf knockdown, double-knockout negative epistasis, single lab","pmids":["38731817","38605277"],"is_preprint":false},{"year":2011,"finding":"In VIP-antagonist-treated mice, reduced Mcph1 expression leads to downregulation of Chk1 and reduced Chk1 kinase activity, turning off neural stem cell proliferation. In vitro silencing of either Mcph1 or Chk1 in neurospheres mimics VIP blockade-induced inhibition of cell proliferation, placing MCPH1 upstream of Chk1 in VIP-mediated cortical development.","method":"VIP antagonist mouse model, qRT-PCR, Western blot, Chk1 kinase activity assay, neurosphere siRNA knockdown","journal":"The Journal of clinical investigation","confidence":"Medium","confidence_rationale":"Tier 2 / Weak — in vivo and in vitro with kinase assay and parallel siRNA knockdown, but mechanistic connection between VIP and MCPH1 is indirect","pmids":["21737879"],"is_preprint":false},{"year":2015,"finding":"The BRUCE UBC E3 ligase domain (not the BIR domain) is required for BRUCE to promote USP8-mediated deubiquitination of BRIT1 after DSB formation; mutation/deletion of the UBC domain does not disrupt BRUCE-USP8-BRIT1 complex formation but impairs BRIT1 deubiquitination, DSB foci formation, and HR repair.","method":"UBC domain mutations/deletions, ubiquitination assay, co-immunoprecipitation, immunofluorescence foci assay, HR repair assay","journal":"PloS one","confidence":"Medium","confidence_rationale":"Tier 2 / Weak — structure-function analysis with separation-of-function mutants, single lab follow-up of prior study","pmids":["26683461"],"is_preprint":false},{"year":2015,"finding":"Loss of MCPH1 causes a CDK2-dependent increase in STIL levels at centrosomes, driving centrosome amplification (CA) in cancer cells. MCPH1 deep gene deletions occur in 5–15% of human cancers depending on anatomic site.","method":"siRNA knockdown in cancer cells, quantitative centrosome immunofluorescence (centriole number), CDK2 inhibition rescue experiment, TCGA genomic analysis for MCPH1 deletions","journal":"Scientific reports","confidence":"Medium","confidence_rationale":"Tier 2 / Weak — cellular mechanistic experiment with CDK2 inhibitor rescue, single lab","pmids":["32681070"],"is_preprint":false},{"year":2015,"finding":"MCPH1 binds to the ANGPT2 promoter and recruits DNA methyltransferases to silence ANGPT2 expression via promoter DNA methylation. MCPH1 knockdown causes ANGPT2 upregulation with loss of promoter methylation.","method":"ChIP (MCPH1 at ANGPT2 promoter), co-immunoprecipitation (MCPH1-DNMT), methylation analysis, MCPH1 knockdown with promoter methylation assay","journal":"The FEBS journal","confidence":"Medium","confidence_rationale":"Tier 2 / Weak — ChIP and Co-IP with mechanistic link to promoter methylation, single lab","pmids":["25703238"],"is_preprint":false},{"year":2019,"finding":"MCPH1 function is required for cellular adaptation to the G2 decatenation checkpoint (bypass of G2 arrest caused by topoisomerase II inhibition), but is dispensable for activation and maintenance of the decatenation checkpoint itself. MCPH1 does not confer adaptation to ATM/ATR-based DNA damage G2 arrest.","method":"MCPH1-depleted HeLa cells, topoisomerase II inhibitor (ICRF-193) G2 arrest assay, checkpoint adaptation assay (live imaging of mitotic entry), ATM/ATR inhibitor comparison","journal":"FASEB journal : official publication of the Federation of American Societies for Experimental Biology","confidence":"Medium","confidence_rationale":"Tier 2 / Weak — functional checkpoint assay with live imaging, single lab, novel role established","pmids":["30964711"],"is_preprint":false},{"year":2012,"finding":"MCPH1 represses hTERT promoter activity by directly binding to the proximal hTERT promoter as shown by EMSA. Overexpression of MCPH1 reduces telomerase activity, and siRNA knockdown of MCPH1 abolishes this repression.","method":"Luciferase reporter assay with hTERT promoter, EMSA (electrophoretic mobility shift assay), siRNA knockdown, telomerase activity assay (TRAP)","journal":"Gene","confidence":"Medium","confidence_rationale":"Tier 2 / Weak — EMSA and reporter assay with functional validation, single lab","pmids":["22240313"],"is_preprint":false},{"year":2022,"finding":"The central domain of MCPH1 (encoded by exon 8) is essential for brain size, gonad development, and prevention of PCC in vivo. Mcph1-Δe8 mice show reduced brain size, thinner cortex, infertility due to germ cell loss, and PCC in MEFs, phenocopying complete Mcph1 knockout.","method":"Mouse model with exon 8 deletion (Mcph1-Δe8), brain morphometry, fertility/gonad histology, MEF chromosome condensation assay","journal":"Cells","confidence":"Medium","confidence_rationale":"Tier 2 / Weak — in vivo mouse model with functional readouts, but primarily phenotypic characterization without new biochemical interaction data","pmids":["36078123"],"is_preprint":false}],"current_model":"MCPH1 (BRIT1) is a multidomain BRCT-containing protein that functions as: (1) a DNA damage sensor recruited to DSBs via its C-terminal tandem BRCT domains binding γH2AX (both pSer139 and pSer139/pTyr142 states), where it recruits the SWI-SNF chromatin remodeling complex (via ATM/ATR-dependent BAF170 phosphorylation) to relax chromatin and facilitate repair factor access; (2) a regulator of homologous recombination by binding RAD51/BRCA2, stabilizing RAD51-ssDNA filaments, and promoting RAD51/BRCA2 recruitment to damage sites; (3) a negative regulator of Condensin II during interphase via direct binding to the NCAPG2/CAPG2 subunit, preventing premature chromosome condensation; (4) a centrosomal protein whose loss abrogates Chk1 centrosomal localization, causing premature Cdk1 activation and early mitotic entry that shifts neuroprogenitor division from symmetric to asymmetric, thereby causing microcephaly; (5) a regulator of Cdc25A degradation through promotion of βTrCP2 E3 ligase activity, itself subject to APC/C-Cdh1-mediated degradation after mitosis; (6) a transcriptional co-regulator cooperating with E2F1 to drive expression of CHK1, BRCA1, RAD51, and p73; and (7) in hematopoietic stem cells, a cytoplasmic suppressor of necroptosis by binding p-RIPK3, with aging-associated KAT7-mediated NLS acetylation driving its nuclear translocation and consequent necroptosis activation."},"narrative":{"mechanistic_narrative":"MCPH1 (BRIT1) is a multidomain BRCT protein that integrates the DNA damage response with chromosome condensation control and cell-cycle timing, and whose loss causes primary microcephaly [PMID:16217032, PMID:bio_10.1101_2025.06.19.660578, PMID:21947081]. As a proximal DNA damage sensor, MCPH1 forms ionizing-radiation-induced nuclear foci within minutes and is required for activation of intra-S and G2/M checkpoints upstream of BRCA1 and Chk1 [PMID:16217032, PMID:bio_10.1101_2025.06.19.660578, PMID:16872911]; its C-terminal tandem BRCT domains dock directly onto phospho-H2AX, reading both the pSer139 and pSer139/pTyr142 marks through a distinctive phosphopeptide pocket [PMID:17925396, PMID:22154951, PMID:22908299], while its N-terminal BRCT domain directs centrosomal localization [PMID:17599047]. Recruitment to breaks is gated by a USP8-catalyzed, BRUCE-scaffolded deubiquitination of K63-linked chains on MCPH1 [PMID:25733871], after which MCPH1 engages the SWI-SNF complex via BAF170 in an ATM/ATR-dependent manner to relax chromatin and license repair-factor access [PMID:19525936]. In homologous recombination, MCPH1 binds RAD51/BRCA2 and single-stranded DNA, stabilizing RAD51-ssDNA filaments and promoting RAD51/BRCA2 loading at damage sites [PMID:20107607, PMID:32735676]. Independently of damage signaling, MCPH1 is a negative regulator of Condensin II during interphase, binding the NCAPG2/CAPG2 subunit through a short linear motif and using its N-terminal BRCT domain to compete for Condensin II chromosomal binding sites, thereby preventing premature chromosome condensation [PMID:18718915, PMID:21911480, PMID:34850681]; the N-terminal BRCT and central (exon 8) domains are each individually essential for brain size, gonad development, and PCC suppression in vivo [PMID:33542216, PMID:36078123]. MCPH1 also controls mitotic timing: it abrogates premature Cdk1 activation by maintaining Chk1 at centrosomes and by promoting βTrCP2-dependent Cdc25A degradation, and its loss switches neuroprogenitor divisions from symmetric to asymmetric to cause microcephaly [PMID:21947081, PMID:29150431]. As a transcriptional co-regulator, MCPH1 cooperates with E2F1 to drive CHK1, BRCA1, RAD51, and p73 expression [PMID:18660752]. A distinct cytoplasmic function maintains hematopoietic stem cells by binding phospho-RIPK3 to suppress necroptosis, an activity lost when aging-associated KAT7-mediated acetylation of the MCPH1 NLS drives nuclear translocation [PMID:38632351].","teleology":[{"year":2005,"claim":"Established MCPH1/BRIT1 as a required upstream component of the DNA damage checkpoint, answering whether it has a functional role in the DDR rather than being a passive marker.","evidence":"siRNA depletion with checkpoint flow cytometry, Western blot, and γH2AX foci co-localization in human cells","pmids":["16217032","bio_10.1101_2025.06.19.660578"],"confidence":"High","gaps":["Did not define the molecular mechanism of recruitment to damage sites","Direct vs. transcriptional contribution to BRCA1/Chk1 reduction unresolved"]},{"year":2006,"claim":"Positioned BRIT1 as a proximal factor in the ATM/ATR pathway by showing rapid focus formation and co-localization with core DDR mediators, and that its loss increases genomic instability.","evidence":"Immunofluorescence foci analysis, co-localization with 53BP1/MDC1/NBS1/ATM/RPA/ATR, and chromosomal aberration assays after siRNA knockdown","pmids":["16872911"],"confidence":"High","gaps":["Did not identify the molecular determinant of focus targeting","Order of recruitment relative to MDC1 not yet resolved"]},{"year":2007,"claim":"Mapped the recruitment mechanism to defined domains, showing the C-terminal tandem BRCT domains bind γH2AX for IRIF formation while the N-terminal BRCT drives centrosomal targeting.","evidence":"BRCT domain deletion/mutation constructs, in vitro peptide binding, and immunofluorescence in H2AX-deficient, MDC1-depleted, ATM/Brca1-deficient cells (including DT40)","pmids":["17925396","17599047"],"confidence":"High","gaps":["Structural basis of the BRCT-phosphopeptide interaction not yet resolved","Centrosomal binding partner unknown"]},{"year":2008,"claim":"Defined how MCPH1 acts after recruitment, linking it to chromatin remodeling, HR repair via Condensin II, and E2F1-dependent transcription of DDR genes.","evidence":"Co-IP, chromatin fractionation/accessibility assays, domain mapping, DR-GFP HR reporter in null MEFs, and ChIP/reporter assays for E2F1 targets","pmids":["19525936","18718915","18660752"],"confidence":"High","gaps":["How SWI-SNF recruitment, HR, and transcription are temporally coordinated unclear","Whether Condensin II binding and HR are mechanistically separable not addressed"]},{"year":2010,"claim":"Distinguished MCPH1's anti-condensation activity from its HR role and validated HR function in vivo, establishing Condensin II as the effector of the PCC phenotype.","evidence":"Selective Condensin I/II subunit depletion in patient cells; BRIT1 knockout mice with γ-irradiation sensitivity, RAD51 foci, meiotic spreads, and RAD51/BRCA2 Co-IP/chromatin fractionation","pmids":["16434882","20107607"],"confidence":"High","gaps":["Biochemical mechanism of RAD51 promotion not yet defined","How MCPH1 distinguishes interphase Condensin II inhibition from repair functions unclear"]},{"year":2011,"claim":"Resolved the structural and mechanistic basis for Condensin II inhibition and microcephaly, showing N-terminal competition for Condensin II, a SET partner, and a centrosomal Chk1-Cdk1-Cdc25b axis controlling neuroprogenitor division mode.","evidence":"Xenopus egg extract reconstitution, crystal structure of N-BRCT with rescue mutagenesis, SET Co-IP/epistasis, and Mcph1-knockout mouse with in vivo Cdc25b rescue","pmids":["21911480","19925808","21515671","21947081"],"confidence":"High","gaps":["How N-BRCT pocket binding to SET relates to Condensin II competition mechanistically unresolved","Direct connection between centrosomal Chk1 loss and division-mode switch incompletely defined"]},{"year":2011,"claim":"Extended BRCT-phosphopeptide reading beyond γH2AX, showing the C-BRCTs bind phospho-Cdc27 of the APC/C, broadening MCPH1's mitotic interaction repertoire.","evidence":"Crystal structure of C-BRCT-pCdc27 peptide complex with in vitro binding and structure-guided mutagenesis","pmids":["22139841"],"confidence":"High","gaps":["Functional consequence of MCPH1-pCdc27 binding for APC/C activity not established"]},{"year":2012,"claim":"Provided structural definition of the C-BRCT phosphopeptide pocket and showed it is distinct from canonical BRCT domains with selectivity for pSer+3 and a free C-terminus.","evidence":"X-ray crystallography of C-BRCTs alone and with γH2AX tail, plus fluorescence polarization binding assays","pmids":["22154951"],"confidence":"High","gaps":["In vivo significance of the C-terminal selectivity not directly tested"]},{"year":2012,"claim":"Demonstrated MCPH1 acts directly on the hTERT promoter to repress telomerase, indicating a sequence-specific transcriptional repressor activity.","evidence":"Luciferase reporter, EMSA, siRNA knockdown, and TRAP telomerase activity assay","pmids":["22240313"],"confidence":"Medium","gaps":["Single lab; direct DNA-binding mode not structurally defined","Cofactors required for repression unidentified"]},{"year":2013,"claim":"Connected MCPH1 loss to a specific neurodevelopmental defect, showing premature neurogenesis skews cortical layer composition without affecting migration.","evidence":"Mcph1 knockout mouse with BrdU/EdU cortical layer birth-dating, HR assays, and TUNEL after irradiation","pmids":["23683352"],"confidence":"High","gaps":["Relative contribution of HR defects vs. mitotic timing to the layering phenotype unresolved"]},{"year":2014,"claim":"Identified additional regulatory roles in p53 stabilization and ATR signaling amplification, linking MCPH1 to tumor suppression and replication-stress responses.","evidence":"Co-IP (MDM2/p53; TopBP1), ubiquitination assays, pSer-322 phospho-antibody, transformation and xenograft assays","pmids":["23729656","25301947"],"confidence":"Medium","gaps":["TopBP1 recruitment role not independently replicated","Mechanism by which MCPH1 blocks MDM2-mediated p53 ubiquitination not structurally defined"]},{"year":2015,"claim":"Defined the upstream gate for MCPH1 recruitment and additional roles in centrosome and gene-silencing control, showing K63-deubiquitination via BRUCE/USP8 is a prerequisite for γH2AX binding.","evidence":"K63-ubiquitination assays, trimeric BRUCE-USP8-BRIT1 Co-IP, UBC domain mutants, BRUCE mutant mice, plus centrosome STIL/CDK2 and ANGPT2 promoter methylation studies","pmids":["25733871","26683461","32681070","25703238"],"confidence":"High","gaps":["STIL/CDK2 and ANGPT2 mechanisms from single labs","How deubiquitination is timed relative to break formation unclear"]},{"year":2017,"claim":"Established MCPH1 as both a regulator and substrate of cell-cycle proteolysis, promoting βTrCP2-dependent Cdc25A degradation while itself being degraded by APC/C-Cdh1, and validated a role in immunoglobulin class switch recombination.","evidence":"Co-IP, degradation assays, in utero electroporation rescue (βTrCP2/Cdc25A), conditional B-cell knockout with Igh ChIP and CSR assays","pmids":["29150431","28724724"],"confidence":"High","gaps":["How the Cdc25A and centrosomal Chk1 axes integrate not fully resolved","CSR role mechanism relative to MDC1 redundancy incompletely mapped"]},{"year":2018,"claim":"Refined the proteolytic control of MCPH1 by showing isoform-specific APC/C-Cdh1 degradation via distinct D-box and KEN-box degrons after mitotic exit.","evidence":"Cell-cycle synchronization, phospho-site identification, APC/C Co-IP, and degron mutagenesis","pmids":["30303738"],"confidence":"Medium","gaps":["Single lab; functional consequence of isoform-specific turnover not established"]},{"year":2019,"claim":"Identified a selective role in decatenation checkpoint adaptation, distinct from ATM/ATR DNA-damage checkpoint control.","evidence":"MCPH1-depleted HeLa cells with ICRF-193 G2 arrest and live-imaging adaptation assays versus ATM/ATR inhibitors","pmids":["30964711"],"confidence":"Medium","gaps":["Single lab; molecular mechanism of adaptation not defined"]},{"year":2020,"claim":"Provided direct biochemical and structural mechanisms for HR and telomere functions, showing MCPH1 stabilizes RAD51-ssDNA filaments and is recruited to telomeres via TRF2 to promote fork progression.","evidence":"Purified-protein reconstitution with single-molecule TPM, RAD51 interaction mapping, crystal structure of MCPH1-TRF2, and telomere TIF/DNA fiber assays","pmids":["32735676","33203878"],"confidence":"High","gaps":["Whether filament stabilization fully accounts for in vivo HR phenotypes not established","Mitochondrial localization role (idx 27) remains correlative"]},{"year":2021,"claim":"Established MCPH1 as a constitutive interphase brake on Condensin II analogous to WAPL on cohesin, binding NCAPG2 and preventing CDK1-independent chromosome compaction, and assigned domain-specific essentiality in vivo.","evidence":"Mcph1 knockout ESC Hi-C, CDK1 inhibition, SMC2-NCAPH2 fusion epistasis, Co-IP, and Mcph1-ΔBR1 mouse phenotyping","pmids":["34850681","33542216"],"confidence":"High","gaps":["Structural basis of the NCAPG2 short-linear-motif interaction not resolved","How interphase Condensin II inhibition is relieved at mitotic onset unclear"]},{"year":2024,"claim":"Revealed a non-nuclear function in hematopoietic stem cells, where cytoplasmic MCPH1 suppresses necroptosis and aging-driven KAT7 acetylation of its NLS redistributes it to the nucleus.","evidence":"Subcellular fractionation, MCPH1-p-RIPK3 Co-IP, acetylation mapping, KAT7 inhibition, NLS mutagenesis, and HSC transplantation assays","pmids":["38632351"],"confidence":"High","gaps":["Whether cytoplasmic anti-necroptotic function operates in other cell types unknown","Structural basis of MCPH1-RIPK3 binding undefined"]},{"year":2024,"claim":"Clarified that p53/p19ARF activation in Mcph1-deficient cells is a consequence rather than a cause of the proliferation defect, refining the senescence and anemia phenotype interpretation.","evidence":"Mcph1 knockout mouse/MEF RNA-seq, p19Arf siRNA rescue, and Mcph1/p53 double-knockout epistasis","pmids":["38731817","38605277"],"confidence":"Medium","gaps":["Primary lesion upstream of p19ARF activation not pinpointed","Single-lab characterization"]},{"year":null,"claim":"How MCPH1's distinct activities — γH2AX-dependent DDR recruitment, RAD51 filament stabilization, interphase Condensin II inhibition, centrosomal Chk1/Cdc25A timing, and cytoplasmic necroptosis suppression — are coordinated within a single cell and which is rate-limiting for microcephaly remains unresolved.","evidence":"","pmids":[],"confidence":"High","gaps":["No unified model integrating nuclear DDR/condensation and cytoplasmic functions","Domain-level determinants of partner selection among γH2AX, NCAPG2, RAD51, and RIPK3 not jointly mapped"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0003677","term_label":"DNA binding","supporting_discovery_ids":[19,35,33]},{"term_id":"GO:0140110","term_label":"transcription regulator activity","supporting_discovery_ids":[6,35,33]},{"term_id":"GO:0098772","term_label":"molecular function regulator activity","supporting_discovery_ids":[5,11,21,24,17]},{"term_id":"GO:0042393","term_label":"histone binding","supporting_discovery_ids":[2,14,15]},{"term_id":"GO:0060090","term_label":"molecular adaptor activity","supporting_discovery_ids":[4,16]}],"localization":[{"term_id":"GO:0005634","term_label":"nucleus","supporting_discovery_ids":[1,2,28]},{"term_id":"GO:0000228","term_label":"nuclear chromosome","supporting_discovery_ids":[1,2,3]},{"term_id":"GO:0005815","term_label":"microtubule organizing center","supporting_discovery_ids":[3,10,32]},{"term_id":"GO:0005829","term_label":"cytosol","supporting_discovery_ids":[28]}],"pathway":[{"term_id":"R-HSA-73894","term_label":"DNA Repair","supporting_discovery_ids":[0,1,4,9,19]},{"term_id":"R-HSA-1640170","term_label":"Cell Cycle","supporting_discovery_ids":[10,17,34]},{"term_id":"R-HSA-4839726","term_label":"Chromatin organization","supporting_discovery_ids":[4,21]},{"term_id":"R-HSA-74160","term_label":"Gene expression (Transcription)","supporting_discovery_ids":[6,33,35]},{"term_id":"R-HSA-1266738","term_label":"Developmental Biology","supporting_discovery_ids":[10,23]},{"term_id":"R-HSA-5357801","term_label":"Programmed Cell Death","supporting_discovery_ids":[28]}],"complexes":["SWI-SNF (via BAF170)","BRUCE-USP8-BRIT1 deubiquitination complex"],"partners":["H2AX","RAD51","BRCA2","NCAPG2/CAPG2","E2F1","TRF2","USP8","RIPK3"],"other_free_text":[]}},"prefetch_data":{"uniprot":{"accession":"Q8NEM0","full_name":"Microcephalin","aliases":[],"length_aa":835,"mass_kda":92.8,"function":"Implicated in chromosome condensation and DNA damage induced cellular responses. May play a role in neurogenesis and regulation of the size of the cerebral cortex","subcellular_location":"Cytoplasm, cytoskeleton, microtubule organizing center, centrosome","url":"https://www.uniprot.org/uniprotkb/Q8NEM0/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":false,"resolved_as":"","url":"https://depmap.org/portal/gene/MCPH1","classification":"Not Classified","n_dependent_lines":76,"n_total_lines":1208,"dependency_fraction":0.06291390728476821},"opencell":{"profiled":false,"resolved_as":"","ensg_id":"","cell_line_id":"","localizations":[],"interactors":[],"url":"https://opencell.sf.czbiohub.org/search/MCPH1","total_profiled":1310},"omim":[{"mim_id":"621507","title":"MICROCEPHALY 31, PRIMARY, AUTOSOMAL RECESSIVE; MCPH31","url":"https://www.omim.org/entry/621507"},{"mim_id":"620183","title":"MICROCEPHALY 30, PRIMARY, AUTOSOMAL RECESSIVE; MCPH30","url":"https://www.omim.org/entry/620183"},{"mim_id":"620047","title":"MICROCEPHALY 29, PRIMARY, AUTOSOMAL RECESSIVE; MCPH29","url":"https://www.omim.org/entry/620047"},{"mim_id":"619453","title":"MICROCEPHALY 28, PRIMARY, AUTOSOMAL RECESSIVE; MCPH28","url":"https://www.omim.org/entry/619453"},{"mim_id":"619180","title":"MICROCEPHALY 27, PRIMARY, AUTOSOMAL DOMINANT; MCPH27","url":"https://www.omim.org/entry/619180"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"","locations":[],"tissue_specificity":"Low tissue specificity","tissue_distribution":"Detected in all","driving_tissues":[],"url":"https://www.proteinatlas.org/search/MCPH1"},"hgnc":{"alias_symbol":["FLJ12847","BRIT1"],"prev_symbol":[]},"alphafold":{"accession":"Q8NEM0","domains":[{"cath_id":"3.40.50.10190","chopping":"11-97","consensus_level":"high","plddt":90.0457,"start":11,"end":97},{"cath_id":"3.40.50.10190","chopping":"648-752","consensus_level":"medium","plddt":95.3879,"start":648,"end":752},{"cath_id":"3.40.50.10190","chopping":"753-835","consensus_level":"medium","plddt":93.7575,"start":753,"end":835}],"viewer_url":"https://alphafold.ebi.ac.uk/entry/Q8NEM0","model_url":"https://alphafold.ebi.ac.uk/files/AF-Q8NEM0-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-Q8NEM0-F1-predicted_aligned_error_v6.png","plddt_mean":59.34},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=MCPH1","jax_strain_url":"https://www.jax.org/strain/search?query=MCPH1"},"sequence":{"accession":"Q8NEM0","fasta_url":"https://rest.uniprot.org/uniprotkb/Q8NEM0.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/Q8NEM0/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/Q8NEM0"}},"corpus_meta":[{"pmid":"21947081","id":"PMC_21947081","title":"MCPH1 regulates the neuroprogenitor division mode by coupling the centrosomal cycle with mitotic entry through the Chk1-Cdc25 pathway.","date":"2011","source":"Nature cell biology","url":"https://pubmed.ncbi.nlm.nih.gov/21947081","citation_count":195,"is_preprint":false},{"pmid":"19525936","id":"PMC_19525936","title":"BRIT1/MCPH1 links chromatin remodelling to DNA damage response.","date":"2009","source":"Nature cell biology","url":"https://pubmed.ncbi.nlm.nih.gov/19525936","citation_count":166,"is_preprint":false},{"pmid":"16217032","id":"PMC_16217032","title":"BRIT1/MCPH1 is a DNA damage responsive protein that regulates the Brca1-Chk1 pathway, implicating checkpoint dysfunction in microcephaly.","date":"2005","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/16217032","citation_count":145,"is_preprint":false},{"pmid":"9683597","id":"PMC_9683597","title":"Primary autosomal recessive microcephaly (MCPH1) maps to chromosome 8p22-pter.","date":"1998","source":"American journal of human genetics","url":"https://pubmed.ncbi.nlm.nih.gov/9683597","citation_count":129,"is_preprint":false},{"pmid":"16872911","id":"PMC_16872911","title":"BRIT1 regulates early DNA damage response, chromosomal integrity, and cancer.","date":"2006","source":"Cancer cell","url":"https://pubmed.ncbi.nlm.nih.gov/16872911","citation_count":122,"is_preprint":false},{"pmid":"18718915","id":"PMC_18718915","title":"Microcephalin/MCPH1 associates with the Condensin II complex to function in homologous recombination repair.","date":"2008","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/18718915","citation_count":94,"is_preprint":false},{"pmid":"20107607","id":"PMC_20107607","title":"BRIT1/MCPH1 is essential for mitotic and meiotic recombination DNA repair and maintaining genomic stability in mice.","date":"2010","source":"PLoS genetics","url":"https://pubmed.ncbi.nlm.nih.gov/20107607","citation_count":89,"is_preprint":false},{"pmid":"17925396","id":"PMC_17925396","title":"MCPH1 functions in an H2AX-dependent but MDC1-independent pathway in response to DNA damage.","date":"2007","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/17925396","citation_count":89,"is_preprint":false},{"pmid":"18660752","id":"PMC_18660752","title":"MCPH1/BRIT1 cooperates with E2F1 in the activation of checkpoint, DNA repair and apoptosis.","date":"2008","source":"EMBO reports","url":"https://pubmed.ncbi.nlm.nih.gov/18660752","citation_count":75,"is_preprint":false},{"pmid":"21911480","id":"PMC_21911480","title":"MCPH1 regulates chromosome condensation and shaping as a composite modulator of condensin II.","date":"2011","source":"The Journal of cell biology","url":"https://pubmed.ncbi.nlm.nih.gov/21911480","citation_count":73,"is_preprint":false},{"pmid":"17599047","id":"PMC_17599047","title":"Distinct BRCT domains in Mcph1/Brit1 mediate ionizing radiation-induced focus formation and centrosomal localization.","date":"2007","source":"Oncogene","url":"https://pubmed.ncbi.nlm.nih.gov/17599047","citation_count":70,"is_preprint":false},{"pmid":"16434882","id":"PMC_16434882","title":"Misregulated chromosome condensation in MCPH1 primary microcephaly is mediated by condensin II.","date":"2006","source":"Cell cycle (Georgetown, Tex.)","url":"https://pubmed.ncbi.nlm.nih.gov/16434882","citation_count":66,"is_preprint":false},{"pmid":"16311745","id":"PMC_16311745","title":"SNP array-based homozygosity mapping reveals MCPH1 deletion in family with autosomal recessive mental retardation and mild microcephaly.","date":"2005","source":"Human genetics","url":"https://pubmed.ncbi.nlm.nih.gov/16311745","citation_count":59,"is_preprint":false},{"pmid":"23683352","id":"PMC_23683352","title":"DNA damage response in microcephaly development of MCPH1 mouse model.","date":"2013","source":"DNA repair","url":"https://pubmed.ncbi.nlm.nih.gov/23683352","citation_count":56,"is_preprint":false},{"pmid":"34691896","id":"PMC_34691896","title":"Transgenic rhesus monkeys carrying the human MCPH1 gene copies show human-like neoteny of brain development.","date":"2019","source":"National science review","url":"https://pubmed.ncbi.nlm.nih.gov/34691896","citation_count":49,"is_preprint":false},{"pmid":"22908299","id":"PMC_22908299","title":"Dual recognition of phosphoserine and phosphotyrosine in histone variant H2A.X by DNA damage response protein MCPH1.","date":"2012","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/22908299","citation_count":47,"is_preprint":false},{"pmid":"20169082","id":"PMC_20169082","title":"Establishment of a mouse model with misregulated chromosome condensation due to defective Mcph1 function.","date":"2010","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/20169082","citation_count":44,"is_preprint":false},{"pmid":"16211557","id":"PMC_16211557","title":"The first missense alteration in the MCPH1 gene causes autosomal recessive microcephaly with an extremely mild cellular and clinical phenotype.","date":"2005","source":"Human mutation","url":"https://pubmed.ncbi.nlm.nih.gov/16211557","citation_count":44,"is_preprint":false},{"pmid":"34850681","id":"PMC_34850681","title":"MCPH1 inhibits Condensin II during interphase by regulating its SMC2-Kleisin interface.","date":"2021","source":"eLife","url":"https://pubmed.ncbi.nlm.nih.gov/34850681","citation_count":42,"is_preprint":false},{"pmid":"25733871","id":"PMC_25733871","title":"BRUCE regulates DNA double-strand break response by promoting USP8 deubiquitination of BRIT1.","date":"2015","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/25733871","citation_count":41,"is_preprint":false},{"pmid":"32294449","id":"PMC_32294449","title":"Cell Metabolic Alterations due to Mcph1 Mutation in Microcephaly.","date":"2020","source":"Cell reports","url":"https://pubmed.ncbi.nlm.nih.gov/32294449","citation_count":39,"is_preprint":false},{"pmid":"23472065","id":"PMC_23472065","title":"Primary microcephaly gene MCPH1 shows signatures of tumor suppressors and is regulated by miR-27a in oral squamous cell carcinoma.","date":"2013","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/23472065","citation_count":39,"is_preprint":false},{"pmid":"18204051","id":"PMC_18204051","title":"A common SNP of MCPH1 is associated with cranial volume variation in Chinese population.","date":"2008","source":"Human molecular genetics","url":"https://pubmed.ncbi.nlm.nih.gov/18204051","citation_count":37,"is_preprint":false},{"pmid":"25870538","id":"PMC_25870538","title":"MCPH1: a window into brain development and evolution.","date":"2015","source":"Frontiers in cellular neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/25870538","citation_count":36,"is_preprint":false},{"pmid":"18636190","id":"PMC_18636190","title":"Expression analysis of the autosomal recessive primary microcephaly genes MCPH1 (microcephalin) and MCPH5 (ASPM, abnormal spindle-like, microcephaly associated) in human malignant gliomas.","date":"2008","source":"Oncology reports","url":"https://pubmed.ncbi.nlm.nih.gov/18636190","citation_count":36,"is_preprint":false},{"pmid":"17895362","id":"PMC_17895362","title":"The Drosophila homolog of MCPH1, a human microcephaly gene, is required for genomic stability in the early embryo.","date":"2007","source":"Journal of cell science","url":"https://pubmed.ncbi.nlm.nih.gov/17895362","citation_count":35,"is_preprint":false},{"pmid":"20376879","id":"PMC_20376879","title":"Multiple roles of BRIT1/MCPH1 in DNA damage response, DNA repair, and cancer suppression.","date":"2010","source":"Yonsei medical journal","url":"https://pubmed.ncbi.nlm.nih.gov/20376879","citation_count":33,"is_preprint":false},{"pmid":"23516444","id":"PMC_23516444","title":"Mcph1-deficient mice reveal a role for MCPH1 in otitis media.","date":"2013","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/23516444","citation_count":33,"is_preprint":false},{"pmid":"19793310","id":"PMC_19793310","title":"Copy number changes of the microcephalin 1 gene (MCPH1) in patients with autism spectrum disorders.","date":"2009","source":"Clinical genetics","url":"https://pubmed.ncbi.nlm.nih.gov/19793310","citation_count":32,"is_preprint":false},{"pmid":"20661222","id":"PMC_20661222","title":"MCPH1/BRIT1 limits ionizing radiation-induced centrosome amplification.","date":"2010","source":"Oncogene","url":"https://pubmed.ncbi.nlm.nih.gov/20661222","citation_count":29,"is_preprint":false},{"pmid":"21515671","id":"PMC_21515671","title":"SET nuclear oncogene associates with microcephalin/MCPH1 and regulates chromosome condensation.","date":"2011","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/21515671","citation_count":29,"is_preprint":false},{"pmid":"27197793","id":"PMC_27197793","title":"The DNA damage response molecule MCPH1 in brain development and beyond.","date":"2016","source":"Acta biochimica et biophysica Sinica","url":"https://pubmed.ncbi.nlm.nih.gov/27197793","citation_count":28,"is_preprint":false},{"pmid":"21934293","id":"PMC_21934293","title":"BRIT1/MCPH1 expression in chronic myeloid leukemia and its regulation of the G2/M checkpoint.","date":"2011","source":"Acta haematologica","url":"https://pubmed.ncbi.nlm.nih.gov/21934293","citation_count":27,"is_preprint":false},{"pmid":"24560403","id":"PMC_24560403","title":"Emerging roles of MCPH1: expedition from primary microcephaly to cancer.","date":"2014","source":"European journal of cell biology","url":"https://pubmed.ncbi.nlm.nih.gov/24560403","citation_count":26,"is_preprint":false},{"pmid":"22952573","id":"PMC_22952573","title":"A novel MCPH1 isoform complements the defective chromosome condensation of human MCPH1-deficient cells.","date":"2012","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/22952573","citation_count":25,"is_preprint":false},{"pmid":"29150431","id":"PMC_29150431","title":"The E3 ubiquitin ligase APC/CCdh1 degrades MCPH1 after MCPH1-βTrCP2-Cdc25A-mediated mitotic entry to ensure neurogenesis.","date":"2017","source":"The EMBO journal","url":"https://pubmed.ncbi.nlm.nih.gov/29150431","citation_count":25,"is_preprint":false},{"pmid":"24013099","id":"PMC_24013099","title":"Combined deletion of two Condensin II system genes (NCAPG2 and MCPH1) in a case of severe microcephaly and mental deficiency.","date":"2013","source":"European journal of medical genetics","url":"https://pubmed.ncbi.nlm.nih.gov/24013099","citation_count":25,"is_preprint":false},{"pmid":"35053391","id":"PMC_35053391","title":"Multifaceted Microcephaly-Related Gene MCPH1.","date":"2022","source":"Cells","url":"https://pubmed.ncbi.nlm.nih.gov/35053391","citation_count":23,"is_preprint":false},{"pmid":"22139841","id":"PMC_22139841","title":"Molecular basis for the association of microcephalin (MCPH1) protein with the cell division cycle protein 27 (Cdc27) subunit of the anaphase-promoting complex.","date":"2011","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/22139841","citation_count":23,"is_preprint":false},{"pmid":"23697381","id":"PMC_23697381","title":"Functional divergence of the brain-size regulating gene MCPH1 during primate evolution and the origin of humans.","date":"2013","source":"BMC biology","url":"https://pubmed.ncbi.nlm.nih.gov/23697381","citation_count":23,"is_preprint":false},{"pmid":"17172830","id":"PMC_17172830","title":"BRIT1/MCPH1: a guardian of genome and an enemy of tumors.","date":"2006","source":"Cell cycle (Georgetown, Tex.)","url":"https://pubmed.ncbi.nlm.nih.gov/17172830","citation_count":22,"is_preprint":false},{"pmid":"25362854","id":"PMC_25362854","title":"Mcph1/Brit1 deficiency promotes genomic instability and tumor formation in a mouse model.","date":"2014","source":"Oncogene","url":"https://pubmed.ncbi.nlm.nih.gov/25362854","citation_count":21,"is_preprint":false},{"pmid":"21150325","id":"PMC_21150325","title":"MCPH1 patient cells exhibit delayed release from DNA damage-induced G2/M checkpoint arrest.","date":"2010","source":"Cell cycle (Georgetown, Tex.)","url":"https://pubmed.ncbi.nlm.nih.gov/21150325","citation_count":21,"is_preprint":false},{"pmid":"21737879","id":"PMC_21737879","title":"VIP blockade leads to microcephaly in mice via disruption of Mcph1-Chk1 signaling.","date":"2011","source":"The Journal of clinical investigation","url":"https://pubmed.ncbi.nlm.nih.gov/21737879","citation_count":21,"is_preprint":false},{"pmid":"26820313","id":"PMC_26820313","title":"Targeted Next-Generation Sequencing Identifies a Recurrent Mutation in MCPH1 Associating with Hereditary Breast Cancer Susceptibility.","date":"2016","source":"PLoS genetics","url":"https://pubmed.ncbi.nlm.nih.gov/26820313","citation_count":21,"is_preprint":false},{"pmid":"29026105","id":"PMC_29026105","title":"MCPH1, mutated in primary microcephaly, is required for efficient chromosome alignment during mitosis.","date":"2017","source":"Scientific reports","url":"https://pubmed.ncbi.nlm.nih.gov/29026105","citation_count":20,"is_preprint":false},{"pmid":"21492470","id":"PMC_21492470","title":"Phylogeny and adaptive evolution of the brain-development gene microcephalin (MCPH1) in cetaceans.","date":"2011","source":"BMC evolutionary biology","url":"https://pubmed.ncbi.nlm.nih.gov/21492470","citation_count":19,"is_preprint":false},{"pmid":"22240313","id":"PMC_22240313","title":"MCPH1/BRIT1 represses transcription of the human telomerase reverse transcriptase gene.","date":"2012","source":"Gene","url":"https://pubmed.ncbi.nlm.nih.gov/22240313","citation_count":18,"is_preprint":false},{"pmid":"33203878","id":"PMC_33203878","title":"Microcephalin 1/BRIT1-TRF2 interaction promotes telomere replication and repair, linking telomere dysfunction to primary microcephaly.","date":"2020","source":"Nature communications","url":"https://pubmed.ncbi.nlm.nih.gov/33203878","citation_count":17,"is_preprint":false},{"pmid":"22154951","id":"PMC_22154951","title":"Specific recognition of phosphorylated tail of H2AX by the tandem BRCT domains of MCPH1 revealed by complex structure.","date":"2011","source":"Journal of structural biology","url":"https://pubmed.ncbi.nlm.nih.gov/22154951","citation_count":17,"is_preprint":false},{"pmid":"33542216","id":"PMC_33542216","title":"The N-terminal BRCT domain determines MCPH1 function in brain development and fertility.","date":"2021","source":"Cell death & disease","url":"https://pubmed.ncbi.nlm.nih.gov/33542216","citation_count":16,"is_preprint":false},{"pmid":"22855649","id":"PMC_22855649","title":"Two Missense Mutations in the Primary Autosomal Recessive Microcephaly Gene MCPH1 Disrupt the Function of the Highly Conserved N-Terminal BRCT Domain of Microcephalin.","date":"2012","source":"Molecular syndromology","url":"https://pubmed.ncbi.nlm.nih.gov/22855649","citation_count":15,"is_preprint":false},{"pmid":"29693325","id":"PMC_29693325","title":"Phenotypes in siblings with homozygous mutations of TRAPPC9 and/or MCPH1 support a bifunctional model of MCPH1.","date":"2018","source":"Molecular genetics & genomic medicine","url":"https://pubmed.ncbi.nlm.nih.gov/29693325","citation_count":14,"is_preprint":false},{"pmid":"24633962","id":"PMC_24633962","title":"The overexpression of MCPH1 inhibits cell growth through regulating cell cycle-related proteins and activating cytochrome c-caspase 3 signaling in cervical cancer.","date":"2014","source":"Molecular and cellular biochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/24633962","citation_count":14,"is_preprint":false},{"pmid":"32681070","id":"PMC_32681070","title":"Analysis of the \"centrosome-ome\" identifies MCPH1 deletion as a cause of centrosome amplification in human cancer.","date":"2020","source":"Scientific reports","url":"https://pubmed.ncbi.nlm.nih.gov/32681070","citation_count":14,"is_preprint":false},{"pmid":"23729656","id":"PMC_23729656","title":"BRIT1 regulates p53 stability and functions as a tumor suppressor in breast cancer.","date":"2013","source":"Carcinogenesis","url":"https://pubmed.ncbi.nlm.nih.gov/23729656","citation_count":13,"is_preprint":false},{"pmid":"26683461","id":"PMC_26683461","title":"The UBC Domain Is Required for BRUCE to Promote BRIT1/MCPH1 Function in DSB Signaling and Repair Post Formation of BRUCE-USP8-BRIT1 Complex.","date":"2015","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/26683461","citation_count":12,"is_preprint":false},{"pmid":"22136275","id":"PMC_22136275","title":"Identification and functional characterization of a primate-specific E2F1 binding motif regulating MCPH1 expression.","date":"2012","source":"The FEBS journal","url":"https://pubmed.ncbi.nlm.nih.gov/22136275","citation_count":11,"is_preprint":false},{"pmid":"29872322","id":"PMC_29872322","title":"Overexpression of MCPH1 inhibits the migration and invasion of lung cancer cells.","date":"2018","source":"OncoTargets and therapy","url":"https://pubmed.ncbi.nlm.nih.gov/29872322","citation_count":11,"is_preprint":false},{"pmid":"26870219","id":"PMC_26870219","title":"Overexpression of MCPH1 inhibits uncontrolled cell growth by promoting cell apoptosis and arresting the cell cycle in S and G2/M phase in lung cancer cells.","date":"2015","source":"Oncology letters","url":"https://pubmed.ncbi.nlm.nih.gov/26870219","citation_count":11,"is_preprint":false},{"pmid":"19925808","id":"PMC_19925808","title":"A pocket on the surface of the N-terminal BRCT domain of Mcph1 is required to prevent abnormal chromosome condensation.","date":"2009","source":"Journal of molecular biology","url":"https://pubmed.ncbi.nlm.nih.gov/19925808","citation_count":11,"is_preprint":false},{"pmid":"25845520","id":"PMC_25845520","title":"Chromosome structure deficiencies in MCPH1 syndrome.","date":"2015","source":"Chromosoma","url":"https://pubmed.ncbi.nlm.nih.gov/25845520","citation_count":10,"is_preprint":false},{"pmid":"29860064","id":"PMC_29860064","title":"Expression analysis of the MCPH1/BRIT1 and BRCA1 tumor suppressor genes and telomerase splice variants in epithelial ovarian cancer.","date":"2018","source":"Gene","url":"https://pubmed.ncbi.nlm.nih.gov/29860064","citation_count":10,"is_preprint":false},{"pmid":"24972868","id":"PMC_24972868","title":"The Drosophila MCPH1-B isoform is a substrate of the APCCdh1 E3 ubiquitin ligase complex.","date":"2014","source":"Biology open","url":"https://pubmed.ncbi.nlm.nih.gov/24972868","citation_count":10,"is_preprint":false},{"pmid":"26192461","id":"PMC_26192461","title":"A case report: Autosomal recessive microcephaly caused by a novel mutation in MCPH1 gene.","date":"2015","source":"Gene","url":"https://pubmed.ncbi.nlm.nih.gov/26192461","citation_count":10,"is_preprint":false},{"pmid":"32735676","id":"PMC_32735676","title":"Microcephaly family protein MCPH1 stabilizes RAD51 filaments.","date":"2020","source":"Nucleic acids research","url":"https://pubmed.ncbi.nlm.nih.gov/32735676","citation_count":9,"is_preprint":false},{"pmid":"25197360","id":"PMC_25197360","title":"Primary microcephaly gene MCPH1 shows a novel molecular biomarker of human renal carcinoma and is regulated by miR-27a.","date":"2014","source":"International journal of clinical and experimental pathology","url":"https://pubmed.ncbi.nlm.nih.gov/25197360","citation_count":9,"is_preprint":false},{"pmid":"24080358","id":"PMC_24080358","title":"MCPH1 deletion in a newborn with severe microcephaly and premature chromosome condensation.","date":"2013","source":"European journal of medical genetics","url":"https://pubmed.ncbi.nlm.nih.gov/24080358","citation_count":9,"is_preprint":false},{"pmid":"30351297","id":"PMC_30351297","title":"Novel compound heterozygous mutations in MCPH1 gene causes primary microcephaly in Saudi family.","date":"2018","source":"Neurosciences (Riyadh, Saudi Arabia)","url":"https://pubmed.ncbi.nlm.nih.gov/30351297","citation_count":9,"is_preprint":false},{"pmid":"36845691","id":"PMC_36845691","title":"The emerging role of MCPH1/BRIT1 in carcinogenesis.","date":"2023","source":"Frontiers in oncology","url":"https://pubmed.ncbi.nlm.nih.gov/36845691","citation_count":8,"is_preprint":false},{"pmid":"38632351","id":"PMC_38632351","title":"Aging-induced MCPH1 translocation activates necroptosis and impairs hematopoietic stem cell function.","date":"2024","source":"Nature aging","url":"https://pubmed.ncbi.nlm.nih.gov/38632351","citation_count":8,"is_preprint":false},{"pmid":"35281599","id":"PMC_35281599","title":"Identification of Pathogenic Mutations in Primary Microcephaly- (MCPH-) Related Three Genes CENPJ, CASK, and MCPH1 in Consanguineous Pakistani Families.","date":"2022","source":"BioMed research international","url":"https://pubmed.ncbi.nlm.nih.gov/35281599","citation_count":8,"is_preprint":false},{"pmid":"32556427","id":"PMC_32556427","title":"Investigation of promoter methylation of MCPH1 gene in circulating cell-free DNA of brain tumor patients.","date":"2020","source":"Experimental brain research","url":"https://pubmed.ncbi.nlm.nih.gov/32556427","citation_count":7,"is_preprint":false},{"pmid":"25703238","id":"PMC_25703238","title":"MCPH1 maintains long-term epigenetic silencing of ANGPT2 in chronic lymphocytic leukemia.","date":"2015","source":"The FEBS journal","url":"https://pubmed.ncbi.nlm.nih.gov/25703238","citation_count":7,"is_preprint":false},{"pmid":"30964711","id":"PMC_30964711","title":"MCPH1 is essential for cellular adaptation to the G2-phase decatenation checkpoint.","date":"2019","source":"FASEB journal : official publication of the Federation of American Societies for Experimental Biology","url":"https://pubmed.ncbi.nlm.nih.gov/30964711","citation_count":7,"is_preprint":false},{"pmid":"25301947","id":"PMC_25301947","title":"Phosphorylation of the BRCA1 C terminus (BRCT) repeat inhibitor of hTERT (BRIT1) protein coordinates TopBP1 protein recruitment and amplifies ataxia telangiectasia-mutated and Rad3-related (ATR) Signaling.","date":"2014","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/25301947","citation_count":7,"is_preprint":false},{"pmid":"23866422","id":"PMC_23866422","title":"A novel mutation in MCPH1 gene in an Iranian family with primary microcephaly.","date":"2012","source":"JPMA. The Journal of the Pakistan Medical Association","url":"https://pubmed.ncbi.nlm.nih.gov/23866422","citation_count":7,"is_preprint":false},{"pmid":"35456440","id":"PMC_35456440","title":"MCPH1: A Novel Case Report and a Review of the Literature.","date":"2022","source":"Genes","url":"https://pubmed.ncbi.nlm.nih.gov/35456440","citation_count":6,"is_preprint":false},{"pmid":"36553323","id":"PMC_36553323","title":"Prenatal Identification of a Novel Mutation in the MCPH1 Gene Associated with Autosomal Recessive Primary Microcephaly (MCPH) Using Next Generation Sequencing (NGS): A Case Report and Review of the Literature.","date":"2022","source":"Children (Basel, Switzerland)","url":"https://pubmed.ncbi.nlm.nih.gov/36553323","citation_count":6,"is_preprint":false},{"pmid":"19829069","id":"PMC_19829069","title":"The linkage of chromatin remodeling to genome maintenance: contribution from a human disease gene BRIT1/MCPH1.","date":"2009","source":"Epigenetics","url":"https://pubmed.ncbi.nlm.nih.gov/19829069","citation_count":5,"is_preprint":false},{"pmid":"36078123","id":"PMC_36078123","title":"The Central Domain of MCPH1 Controls Development of the Cerebral Cortex and Gonads in Mice.","date":"2022","source":"Cells","url":"https://pubmed.ncbi.nlm.nih.gov/36078123","citation_count":5,"is_preprint":false},{"pmid":"32642299","id":"PMC_32642299","title":"BRIT1 dysfunction confers synergistic inhibition of hepatocellular carcinoma by targeting poly (ADP-ribose) polymerases and PI3K.","date":"2020","source":"American journal of cancer research","url":"https://pubmed.ncbi.nlm.nih.gov/32642299","citation_count":5,"is_preprint":false},{"pmid":"28724724","id":"PMC_28724724","title":"BRCT-domain protein BRIT1 influences class switch recombination.","date":"2017","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/28724724","citation_count":4,"is_preprint":false},{"pmid":"30303738","id":"PMC_30303738","title":"Phosphorylation of MCPH1 isoforms during mitosis followed by isoform-specific degradation by APC/C-CDH1.","date":"2018","source":"FASEB journal : official publication of the Federation of American Societies for Experimental Biology","url":"https://pubmed.ncbi.nlm.nih.gov/30303738","citation_count":4,"is_preprint":false},{"pmid":"32714618","id":"PMC_32714618","title":"Primary Microcephaly with Novel Variant of MCPH1 Gene in Twins: Both Manifesting in Childhood at the Same Time with Hashimoto's Thyroiditis.","date":"2020","source":"Journal of pediatric genetics","url":"https://pubmed.ncbi.nlm.nih.gov/32714618","citation_count":3,"is_preprint":false},{"pmid":"38463519","id":"PMC_38463519","title":"The analyses of human MCPH1 DNA repair machinery and genetic variations.","date":"2024","source":"Open medicine (Warsaw, Poland)","url":"https://pubmed.ncbi.nlm.nih.gov/38463519","citation_count":2,"is_preprint":false},{"pmid":"30337515","id":"PMC_30337515","title":"Silencing BRIT1 Facilitates the Abilities of Invasiveness and Migration in Trophoblast Cells.","date":"2018","source":"Medical science monitor : international medical journal of experimental and clinical research","url":"https://pubmed.ncbi.nlm.nih.gov/30337515","citation_count":2,"is_preprint":false},{"pmid":"30859703","id":"PMC_30859703","title":"Genetic association and functional characterization of MCPH1 gene variation in bipolar disorder and schizophrenia.","date":"2019","source":"American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics","url":"https://pubmed.ncbi.nlm.nih.gov/30859703","citation_count":2,"is_preprint":false},{"pmid":"33370873","id":"PMC_33370873","title":"Generation of a MCPH1 knockout human embryonic stem cell line by CRISPR/Cas9 technology.","date":"2020","source":"Stem cell research","url":"https://pubmed.ncbi.nlm.nih.gov/33370873","citation_count":2,"is_preprint":false},{"pmid":"19267414","id":"PMC_19267414","title":"The c.940G variant of the Microcephalin (MCPH1) gene is not associated with microcephaly or mental retardation.","date":"2009","source":"American journal of medical genetics. Part A","url":"https://pubmed.ncbi.nlm.nih.gov/19267414","citation_count":2,"is_preprint":false},{"pmid":"28878824","id":"PMC_28878824","title":"CMA analysis identifies homozygous deletion of MCPH1 in 2 brothers with primary Microcephaly-1.","date":"2017","source":"Molecular cytogenetics","url":"https://pubmed.ncbi.nlm.nih.gov/28878824","citation_count":2,"is_preprint":false},{"pmid":"38731817","id":"PMC_38731817","title":"Microcephaly Gene Mcph1 Deficiency Induces p19ARF-Dependent Cell Cycle Arrest and Senescence.","date":"2024","source":"International journal of molecular sciences","url":"https://pubmed.ncbi.nlm.nih.gov/38731817","citation_count":1,"is_preprint":false},{"pmid":"38818167","id":"PMC_38818167","title":"Functional analysis of a novel intronic variant of MCPH1 with autosomal recessive primary microcephaly.","date":"2024","source":"Heliyon","url":"https://pubmed.ncbi.nlm.nih.gov/38818167","citation_count":1,"is_preprint":false},{"pmid":"32276518","id":"PMC_32276518","title":"MCPH1 Lack of Function Enhances Mitotic Cell Sensitivity Caused by Catalytic Inhibitors of Topo II.","date":"2020","source":"Genes","url":"https://pubmed.ncbi.nlm.nih.gov/32276518","citation_count":1,"is_preprint":false},{"pmid":"38605277","id":"PMC_38605277","title":"Mcph1, mutated in primary microcephaly, is also crucial for erythropoiesis.","date":"2024","source":"EMBO reports","url":"https://pubmed.ncbi.nlm.nih.gov/38605277","citation_count":0,"is_preprint":false},{"pmid":"39280843","id":"PMC_39280843","title":"Generation and analysis of mouse embryonic stem cells with knockout of the Mcph1 (microcephalin) gene.","date":"2024","source":"Vavilovskii zhurnal genetiki i selektsii","url":"https://pubmed.ncbi.nlm.nih.gov/39280843","citation_count":0,"is_preprint":false},{"pmid":"41931484","id":"PMC_41931484","title":"Differential sensitivity of MCPH1- and BRCA2-deficient cancer cells to PARP-1 inhibition.","date":"2026","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/41931484","citation_count":0,"is_preprint":false},{"pmid":"26912502","id":"PMC_26912502","title":"The Impact of rs3762271 and rs930557 Polymorphisms of ASPM and MCPH1 Genes on the Anatomy and Function of the Brain.","date":"2016","source":"Biological research for nursing","url":"https://pubmed.ncbi.nlm.nih.gov/26912502","citation_count":0,"is_preprint":false},{"pmid":null,"id":"bio_10.1101_2025.06.19.660578","title":"Correction: Replication of BRIT1/MCPH1 G2/M Checkpoint Function Confirms Original Conclusions","date":"2025-06-22","source":"bioRxiv","url":"https://doi.org/10.1101/2025.06.19.660578","citation_count":0,"is_preprint":true},{"pmid":null,"id":"bio_10.1101_2025.08.08.669285","title":"Condensins-mediated mitotic folding persists as a structural echo in interphase chromatin","date":"2025-08-11","source":"bioRxiv","url":"https://doi.org/10.1101/2025.08.08.669285","citation_count":0,"is_preprint":true}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":46639,"output_tokens":9802,"usd":0.143474,"stage1_stop_reason":"end_turn"},"stage2":{"model":"claude-opus-4-8","input_tokens":20242,"output_tokens":6631,"usd":0.133492,"stage2_stop_reason":"end_turn"},"total_usd":0.276966,"stage1_batch_id":"msgbatch_01BbTCMyrRPyhtEq6b1MdwCN","stage2_batch_id":"msgbatch_011dEed5bbxYvTAaQWKJevxu","note":"batch pricing = 50% of standard"},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 2005,\n      \"finding\": \"BRIT1/MCPH1 is required for activation of both intra-S and G2/M checkpoints in response to ionizing radiation; depletion of BRIT1 abolishes IR-induced cell cycle arrest and reduces expression of BRCA1 and Chk1, and phosphorylation of Nbs1, placing BRIT1 upstream of BRCA1-Chk1 in the DNA damage response pathway.\",\n      \"method\": \"siRNA depletion in human cells, cell cycle checkpoint assays (flow cytometry), Western blot, immunofluorescence co-localization with γ-H2AX foci\",\n      \"journal\": \"Proceedings of the National Academy of Sciences of the United States of America\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — multiple orthogonal methods (checkpoint assay, Western blot, foci co-localization), independently replicated and confirmed by follow-up replication study (PMID:bio_10.1101_2025.06.19.660578)\",\n      \"pmids\": [\"16217032\", \"bio_10.1101_2025.06.19.660578\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2006,\n      \"finding\": \"BRIT1 forms IR-induced nuclear foci within minutes of irradiation and co-localizes with 53BP1, MDC1, NBS1, ATM, RPA, and ATR; BRIT1 depletion impairs activation of these DDR elements, identifying BRIT1 as a proximal factor in ATM/ATR pathways and its loss increases chromosomal aberrations.\",\n      \"method\": \"Immunofluorescence foci analysis, co-localization studies, siRNA knockdown, chromosomal aberration assays\",\n      \"journal\": \"Cancer cell\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — multiple orthogonal methods (foci analysis, co-localization, chromosomal aberration assays), consistent with findings from independent labs\",\n      \"pmids\": [\"16872911\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2007,\n      \"finding\": \"MCPH1 localizes to sites of DNA double-strand breaks via its C-terminal tandem BRCT domains, which bind phospho-H2AX (γH2AX) in vitro; this localization depends on H2AX phosphorylation but is independent of MDC1. Overexpression of wild-type but not C-BRCT mutant MCPH1 interferes with MDC1 and 53BP1 foci formation.\",\n      \"method\": \"BRCT domain deletion/mutation constructs, co-immunoprecipitation, in vitro peptide binding assay, immunofluorescence in H2AX-deficient and MDC1-depleted cells\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — domain mapping with mutagenesis, in vitro binding, multiple cell line validations, replicated by structural studies\",\n      \"pmids\": [\"17925396\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2007,\n      \"finding\": \"MCPH1's C-terminal tandem BRCT domains (BRCT2+BRCT3) are required for ionizing radiation-induced nuclear focus (IRIF) formation, while the N-terminal BRCT1 domain is required for centrosomal localization in irradiated cells. Centrosomal targeting is independent of ATM, Brca1, and Chk1 but IRIF formation requires H2AX.\",\n      \"method\": \"Domain deletion constructs, immunofluorescence in ATM-deficient, Brca1-deficient, and H2AX-deficient cell lines (chicken DT40 system)\",\n      \"journal\": \"Oncogene\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — multiple domain mutants tested across multiple genetic backgrounds with orthogonal methods\",\n      \"pmids\": [\"17599047\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2008,\n      \"finding\": \"BRIT1/MCPH1 increases its interaction with the SWI-SNF chromatin remodeling complex (via the BAF170 subunit) after DNA damage in an ATM/ATR-dependent phosphorylation-dependent manner, recruiting SWI-SNF to DNA lesions to promote chromatin relaxation and facilitate repair factor recruitment.\",\n      \"method\": \"Co-immunoprecipitation, chromatin fractionation, siRNA knockdown, chromatin accessibility assay (micrococcal nuclease sensitivity), ATM/ATR inhibition\",\n      \"journal\": \"Nature cell biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — multiple orthogonal methods (Co-IP, chromatin fractionation, accessibility assay), mechanistically defined pathway\",\n      \"pmids\": [\"19525936\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2008,\n      \"finding\": \"MCPH1 physically interacts with Condensin II via its CAPG2 subunit, through MCPH1's middle domain (residues 376–485). Condensin II depletion causes defects in homologous recombination (HR) repair similar to those in MCPH1-null MEFs, and the Condensin II-binding region of MCPH1 is required for HR function.\",\n      \"method\": \"Co-immunoprecipitation, domain mapping, siRNA knockdown, HR repair assay (DR-GFP reporter), MCPH1-null MEFs\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — reciprocal Co-IP, domain mapping, functional rescue assay, genetic validation in knockout MEFs\",\n      \"pmids\": [\"18718915\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2008,\n      \"finding\": \"MCPH1 cooperates with E2F1 to regulate transcription of CHK1, BRCA1, RAD51, DDB2, TOPBP1, p73, and caspases by physically interacting with E2F1 on their promoters. MCPH1 forms oligomers via its second and third BRCT domains; a dominant-negative oligomerization domain mutant blocks MCPH1-E2F1 interaction and inhibits p73 induction and E2F1-dependent apoptosis.\",\n      \"method\": \"Co-immunoprecipitation, chromatin immunoprecipitation (ChIP), reporter gene assays, siRNA knockdown, dominant-negative mutant overexpression, apoptosis assays\",\n      \"journal\": \"EMBO reports\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — ChIP, Co-IP, and functional assays with dominant-negative mutant, multiple target genes tested\",\n      \"pmids\": [\"18660752\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2009,\n      \"finding\": \"The X-ray crystal structure of the human MCPH1 N-terminal BRCT domain (Mcph1N) at 1.6 Å resolution reveals an elongated β1-α1 loop and a hydrophobic pocket in the equivalent position of phosphate-binding sites. Mutations in this pocket abrogate MCPH1's ability to rescue the premature chromosome condensation (PCC) phenotype in Mcph1−/− MEFs, indicating this pocket forms a protein-protein interaction site required to prevent PCC.\",\n      \"method\": \"X-ray crystallography, site-directed mutagenesis, complementation assay in Mcph1−/− MEFs (PCC phenotype rescue)\",\n      \"journal\": \"Journal of molecular biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — crystal structure with functional mutagenesis and cellular rescue assay, rigorous mechanistic validation\",\n      \"pmids\": [\"19925808\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2010,\n      \"finding\": \"In MCPH1-deficient patient cells, siRNA-mediated depletion of Condensin II subunits (but not Condensin I) reverses premature chromosome condensation in G1 and G2, demonstrating that Condensin II activity is required for the PCC phenotype caused by MCPH1 deficiency. Condensin I remains cytoplasmic in prophase-like MCPH1-deficient cells.\",\n      \"method\": \"siRNA knockdown of Condensin I/II subunits in MCPH1 patient cells, cell cycle staging by FACS and microscopy, subcellular fractionation\",\n      \"journal\": \"Cell cycle (Georgetown, Tex.)\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — epistasis via selective subunit depletion, confirmed in both patient cells and HeLa cells\",\n      \"pmids\": [\"16434882\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2010,\n      \"finding\": \"BRIT1/MCPH1 knockout mice are hypersensitive to γ-irradiation, exhibit severe chromatid breaks, reduced RAD51 foci formation after IR, and infertility due to impaired meiotic homologous recombination. BRIT1 binds RAD51/BRCA2 complexes and its absence reduces recruitment of RAD51 and BRCA2 to chromatin at damage sites without altering their protein levels.\",\n      \"method\": \"BRIT1 knockout mouse model, γ-irradiation sensitivity assays, immunofluorescence for RAD51 foci, meiotic chromosome spread analysis, co-immunoprecipitation (BRIT1-RAD51/BRCA2 interaction), chromatin fractionation\",\n      \"journal\": \"PLoS genetics\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — knockout mouse with multiple orthogonal in vivo and in vitro methods, Co-IP, chromatin fractionation\",\n      \"pmids\": [\"20107607\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"MCPH1 disruption in mice causes primary microcephaly through premature switching of neuroprogenitors from symmetric to asymmetric division. Mechanistically, MCPH1 deficiency abrogates Chk1 localization to centrosomes, causing premature Cdk1 activation and early mitotic entry, uncoupling the centrosome cycle from mitosis. Silencing of Cdc25b (a centrosomal Chk1 substrate) rescues spindle misalignment and premature neurogenesis in Mcph1-knockout neocortex.\",\n      \"method\": \"Mcph1 knockout mouse model, immunofluorescence for Chk1 at centrosomes, Cdk1 activity assay, spindle orientation analysis, Cdc25b siRNA in vivo rescue, clonal analysis of neuroprogenitor division mode\",\n      \"journal\": \"Nature cell biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — in vivo genetic rescue (Cdc25b silencing) plus multiple cellular readouts in knockout model, epistasis established\",\n      \"pmids\": [\"21947081\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"hMCPH1's N-terminal domain specifically inhibits Condensin II by competing for its chromosomal binding sites in a Xenopus egg extract cell-free assay. The N-terminal domain alone is sufficient to rescue the PCC phenotype in patient cells; the central domain plays an auxiliary role in chromosome shaping by physically interacting with Condensin II.\",\n      \"method\": \"Xenopus egg extract cell-free chromosome condensation assay, domain deletion constructs, complementation assay in MCPH1 patient cells, co-immunoprecipitation\",\n      \"journal\": \"The Journal of cell biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — cell-free reconstitution assay combined with domain mapping and patient cell complementation\",\n      \"pmids\": [\"21911480\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"SET nuclear oncogene is a direct binding partner of the MCPH1 N-terminal BRCT domain. SET knockdown causes abnormal chromosome condensation that is rescued by Condensin II knockdown. MCPH1 missense mutations (V50G/I51V) that impair SET binding fail to fully rescue chromosome condensation in Mcph1−/− MEFs.\",\n      \"method\": \"Co-immunoprecipitation, siRNA knockdown, complementation assay in Mcph1−/− MEFs, missense mutagenesis\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — Co-IP, epistasis via double knockdown, functional rescue with separation-of-function mutant\",\n      \"pmids\": [\"21515671\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"MCPH1 C-terminal tandem BRCT domains bind phospho-Cdc27 (a component of APC/C) in a phosphorylation-dependent manner. The crystal structure of MCPH1 C-BRCTs in complex with a phosphorylated Cdc27 peptide was determined, and structure-guided mutations disrupted the interaction in vitro and in cells.\",\n      \"method\": \"X-ray crystallography of C-BRCT–pCdc27 peptide complex, in vitro binding assays, co-immunoprecipitation, structure-guided mutagenesis\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — crystal structure with in vitro binding and mutagenesis, multiple orthogonal methods\",\n      \"pmids\": [\"22139841\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"Crystal structures of MCPH1 C-terminal tandem BRCT domains (alone and in complex with γH2AX tail) reveal a phosphopeptide binding pocket distinct from other BRCT domains; fluorescence polarization assays show selectivity for pSer+3 and preference for phosphopeptide with free COOH-terminus.\",\n      \"method\": \"X-ray crystallography, fluorescence polarization binding assay\",\n      \"journal\": \"Journal of structural biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — crystal structure with biochemical binding assay, dual structural validation\",\n      \"pmids\": [\"22154951\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"MCPH1 tandem BRCT domains can read both pSer139 (monophosphorylated) and the diphosphorylated (pSer139/pTyr142) states of H2A.X. Structural, biochemical, and cellular evidence show that MCPH1 recruitment to DNA damage sites is linked to both H2A.X phosphorylation states, making MCPH1 a dual sensor of H2A.X marks.\",\n      \"method\": \"X-ray crystallography (structural analysis), biochemical binding assays, cellular recruitment assays (immunofluorescence), mutagenesis\",\n      \"journal\": \"Proceedings of the National Academy of Sciences of the United States of America\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — crystal structure combined with biochemical and cellular validation, multiple orthogonal methods\",\n      \"pmids\": [\"22908299\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"BRIT1/MCPH1 is K63-ubiquitinated in unstimulated cells, and deubiquitination by USP8 is a prerequisite for BRIT1 recruitment to DSB sites via γH2AX. BRUCE acts as a scaffold bridging USP8 and BRIT1 to coordinate USP8-catalyzed deubiquitination. Loss of BRUCE or USP8 impairs BRIT1 deubiquitination, its binding to γH2AX, and chromatin relaxation.\",\n      \"method\": \"Ubiquitination assays (K63 linkage), co-immunoprecipitation (BRUCE-USP8-BRIT1 complex), siRNA knockdown, immunofluorescence foci assay, HR repair assay, BRUCE mutant mice\",\n      \"journal\": \"Proceedings of the National Academy of Sciences of the United States of America\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — biochemical ubiquitination assay, trimeric complex Co-IP, in vivo mouse model validation, multiple orthogonal methods\",\n      \"pmids\": [\"25733871\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"MCPH1 interacts with βTrCP2 E3 ligase and promotes degradation of Cdc25A independent of DNA damage, thereby regulating G2/M mitotic entry. MCPH1 itself is degraded by APC/C-Cdh1 (not APC/C-Cdc20) in late mitosis/G1. Overexpression of βTrCP2 or knockdown of Cdc25A rescues premature differentiation of Mcph1-deficient neuroprogenitors in vivo.\",\n      \"method\": \"Co-immunoprecipitation (MCPH1-βTrCP2), protein degradation assays, in utero electroporation (siRNA/overexpression), immunofluorescence, APC/C substrate assays\",\n      \"journal\": \"The EMBO journal\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — Co-IP, in vivo genetic rescue, multiple degradation assays, epistasis established\",\n      \"pmids\": [\"29150431\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"BRIT1/MCPH1 is recruited to the Ig heavy chain (Igh) locus in an activation-induced cytidine deaminase (AID)- and H2AX-dependent manner. Conditional deletion of BRIT1 in B cells leads to increased unrepaired Igh breaks and reduced class switch recombination (CSR). The C-terminal BRCT domains facilitate interaction with phospho-H2AX, and BRIT1 depletion worsens CSR defects when combined with MDC1 depletion.\",\n      \"method\": \"Conditional knockout mouse model, ChIP at Igh locus, CSR assays (FACS for IgG subclasses), co-immunoprecipitation, shRNA screen, double knockdown\",\n      \"journal\": \"Proceedings of the National Academy of Sciences of the United States of America\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — conditional knockout mouse, ChIP, functional CSR assay, epistasis with MDC1\",\n      \"pmids\": [\"28724724\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"MCPH1 directly binds to single-stranded DNA and directly interacts with RAD51 at multiple contact points. MCPH1 enhances stability of RAD51-ssDNA filaments approximately 2-fold (single-molecule tethered particle motion), providing a biochemical mechanism for MCPH1's role in HR repair.\",\n      \"method\": \"Purified recombinant MCPH1 protein from mammalian expression system, DNA binding assays, co-immunoprecipitation with RAD51, single-molecule tethered particle motion analysis of RAD51-ssDNA filament lifetime\",\n      \"journal\": \"Nucleic acids research\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — reconstitution with purified proteins, single-molecule analysis, multiple interaction mapping experiments\",\n      \"pmids\": [\"32735676\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"MCPH1 specifically interacts with the TRFH domain of TRF2 via its 330YRLSP334 motif, as revealed by crystal structure. TRF2-dependent recruitment of MCPH1 promotes localization of DNA damage factors and homology-directed repair at dysfunctional telomeres lacking POT1-TPP1, and MCPH1 promotes telomere replication fork progression and restart of stalled forks.\",\n      \"method\": \"Crystal structure of MCPH1-TRF2 complex, co-immunoprecipitation, immunofluorescence at telomeres (TIF assay), replication fork assay (DNA fiber), telomere replication stress assays\",\n      \"journal\": \"Nature communications\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — crystal structure, functional cellular assays, multiple orthogonal methods\",\n      \"pmids\": [\"33203878\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"MCPH1 inhibits Condensin II during interphase by binding to the NCAPG2 subunit of Condensin II via a short linear motif. Deletion of Mcph1 in mouse ESCs unleashes Condensin II to form compact chromosomes in G1 and G2 phases even without CDK1 activity, with enhanced A/B compartment mixing. MCPH1's ability to block Condensin II chromatin association is abrogated by fusion of SMC2 with NCAPH2, analogous to cohesin regulation by WAPL.\",\n      \"method\": \"Mcph1 knockout mouse ESCs, Hi-C chromatin architecture analysis, CDK1 inhibition experiments, SMC2-NCAPH2 fusion construct, co-immunoprecipitation, fluorescence microscopy\",\n      \"journal\": \"eLife\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — genetic knockout, structural (Hi-C), biochemical (Co-IP), epistasis with SMC2-NCAPH2 fusion, CDK1 independence established\",\n      \"pmids\": [\"34850681\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"The N-terminal BRCT domain of MCPH1 is essential for brain size determination, gonad development, DNA damage response, and prevention of premature chromosome condensation (PCC) in vivo. Mouse model lacking only the N-BRCT domain (Mcph1-ΔBR1) recapitulates all phenotypes of complete Mcph1 knockout, including microcephaly, infertility, and PCC.\",\n      \"method\": \"Mouse model (Mcph1-ΔBR1 deletion), brain size measurement, fertility assays, MEF DNA damage response assays, chromosome condensation analysis (PCC phenotype)\",\n      \"journal\": \"Cell death & disease\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — domain-specific in vivo mouse model with comprehensive phenotypic and cellular analysis\",\n      \"pmids\": [\"33542216\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2013,\n      \"finding\": \"Deletion of Mcph1 results in a specific reduction of cerebral cortex at birth with premature neurogenic production causing excess early-born deep-layer neurons (IV-VI) and fewer late-born upper-layer neurons (II-III), without affecting neuronal migration. Mcph1 deletion also compromises homologous recombination repair and increases genomic instability. IR causes massive apoptosis in Mcph1-null neocortex.\",\n      \"method\": \"Mcph1 knockout mouse model, BrdU/EdU birth-dating of cortical layers, HR repair assay (RAD51 foci, comet assay), γ-irradiation survival, TUNEL apoptosis assay\",\n      \"journal\": \"DNA repair\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — knockout mouse model with layer-specific birth-dating, multiple HR assays\",\n      \"pmids\": [\"23683352\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"BRIT1 regulates p53 protein stability post-transcriptionally by blocking MDM2-mediated p53 ubiquitination. BRIT1 knockdown in normal breast epithelial cells causes oncogenic transformation. BRIT1 overexpression suppresses breast cancer cell proliferation in vitro and tumor growth in vivo.\",\n      \"method\": \"Co-immunoprecipitation (BRIT1-MDM2-p53), ubiquitination assay, BRIT1 knockdown in MCF10A cells (transformation assay), soft agar colony formation, xenograft tumor model\",\n      \"journal\": \"Carcinogenesis\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — biochemical ubiquitination mechanism, multiple functional assays in vitro and in vivo\",\n      \"pmids\": [\"23729656\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"BRIT1 phosphorylation at Ser-322 by ATM or ATR in response to replication stress facilitates recruitment of TopBP1 (a key ATR activator) to DNA damage sites, amplifying ATR signaling. BRIT1 is dispensable for ATR initiation but required for amplification of ATR-dependent signaling.\",\n      \"method\": \"Co-immunoprecipitation (BRIT1-TopBP1), phospho-specific antibody for pSer-322, siRNA knockdown, ChIP at damage sites, ATR signaling assays\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Weak — Co-IP and phospho-site mapping in single lab, mechanistically defined but not yet independently replicated\",\n      \"pmids\": [\"25301947\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"Both MCPH1 isoforms are phosphorylated in a CDK1-dependent manner during mitosis. Upon mitotic exit, both isoforms are degraded by APC/C-Cdh1 E3 ligase; the long isoform via a D-Box degron and the short isoform via a KEN-Box degron, demonstrating isoform-specific degradation mechanisms.\",\n      \"method\": \"Cell cycle synchronization, phospho-proteomics/site identification, co-immunoprecipitation with APC/C components, proteasome inhibitor experiments, D-box and KEN-box mutagenesis\",\n      \"journal\": \"FASEB journal : official publication of the Federation of American Societies for Experimental Biology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Weak — multiple methods (synchronization, mutagenesis, Co-IP) but single lab\",\n      \"pmids\": [\"30303738\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"Mcph1 is expressed at mitochondria in apical radial glial cells and controls their proliferation/survival potentially through interactions with VDAC1/GRP75 and AKT/HK2/VDAC1 (mitochondrial activity) and ATF4/PCK2 (glutaminolysis) pathways.\",\n      \"method\": \"Immunofluorescence co-localization (MCPH1 and mitochondrial markers), Mcph1 knockout mouse cortex, transcriptomic analysis, Western blot for pathway components\",\n      \"journal\": \"Cell reports\",\n      \"confidence\": \"Low\",\n      \"confidence_rationale\": \"Tier 3 / Weak — co-localization and knockout transcriptomics, mechanistic link to metabolic pathways is correlative without direct biochemical interaction validation\",\n      \"pmids\": [\"32294449\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2024,\n      \"finding\": \"In hematopoietic stem cells, MCPH1 is present in both nucleus (maintaining genomic stability) and cytoplasm (preventing necroptosis by binding phospho-RIPK3). Aging triggers KAT7-mediated acetylation of the MCPH1 NLS motif, promoting nuclear translocation, reducing cytoplasmic MCPH1, and activating RIPK3-dependent necroptosis and HSC deterioration.\",\n      \"method\": \"Subcellular fractionation, co-immunoprecipitation (MCPH1-p-RIPK3), acetylation mapping, KAT7 inhibition/knockdown, NLS acetylation site mutagenesis, HSC functional assays (transplantation), necroptosis inhibitor rescue\",\n      \"journal\": \"Nature aging\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — Co-IP with p-RIPK3, acetyltransferase identification, NLS mutagenesis, functional HSC assays, mechanistic epistasis established\",\n      \"pmids\": [\"38632351\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2024,\n      \"finding\": \"Mcph1 knockout in mice leads to p19ARF upregulation in MEFs, causing CDK-inhibitor p21-dependent cell cycle arrest and cellular senescence. Silencing p19Arf rescues cell cycle and growth arrest to wild-type levels. p53 pathway activation in Mcph1-deficient erythroid precursors leads to Cdkn1a/p21 overexpression. However, p53 inactivation does not reverse anemia or microcephaly in Mcph1-null mice, suggesting p53 activation is a consequence rather than a cause of the proliferation defect.\",\n      \"method\": \"Mcph1 knockout mouse/MEF model, RNA-seq transcriptomics, p19Arf siRNA rescue, cell cycle assays, Mcph1/p53 double-knockout analysis\",\n      \"journal\": \"International journal of molecular sciences / EMBO reports\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Weak — genetic rescue via p19Arf knockdown, double-knockout negative epistasis, single lab\",\n      \"pmids\": [\"38731817\", \"38605277\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"In VIP-antagonist-treated mice, reduced Mcph1 expression leads to downregulation of Chk1 and reduced Chk1 kinase activity, turning off neural stem cell proliferation. In vitro silencing of either Mcph1 or Chk1 in neurospheres mimics VIP blockade-induced inhibition of cell proliferation, placing MCPH1 upstream of Chk1 in VIP-mediated cortical development.\",\n      \"method\": \"VIP antagonist mouse model, qRT-PCR, Western blot, Chk1 kinase activity assay, neurosphere siRNA knockdown\",\n      \"journal\": \"The Journal of clinical investigation\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Weak — in vivo and in vitro with kinase assay and parallel siRNA knockdown, but mechanistic connection between VIP and MCPH1 is indirect\",\n      \"pmids\": [\"21737879\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"The BRUCE UBC E3 ligase domain (not the BIR domain) is required for BRUCE to promote USP8-mediated deubiquitination of BRIT1 after DSB formation; mutation/deletion of the UBC domain does not disrupt BRUCE-USP8-BRIT1 complex formation but impairs BRIT1 deubiquitination, DSB foci formation, and HR repair.\",\n      \"method\": \"UBC domain mutations/deletions, ubiquitination assay, co-immunoprecipitation, immunofluorescence foci assay, HR repair assay\",\n      \"journal\": \"PloS one\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Weak — structure-function analysis with separation-of-function mutants, single lab follow-up of prior study\",\n      \"pmids\": [\"26683461\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"Loss of MCPH1 causes a CDK2-dependent increase in STIL levels at centrosomes, driving centrosome amplification (CA) in cancer cells. MCPH1 deep gene deletions occur in 5–15% of human cancers depending on anatomic site.\",\n      \"method\": \"siRNA knockdown in cancer cells, quantitative centrosome immunofluorescence (centriole number), CDK2 inhibition rescue experiment, TCGA genomic analysis for MCPH1 deletions\",\n      \"journal\": \"Scientific reports\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Weak — cellular mechanistic experiment with CDK2 inhibitor rescue, single lab\",\n      \"pmids\": [\"32681070\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"MCPH1 binds to the ANGPT2 promoter and recruits DNA methyltransferases to silence ANGPT2 expression via promoter DNA methylation. MCPH1 knockdown causes ANGPT2 upregulation with loss of promoter methylation.\",\n      \"method\": \"ChIP (MCPH1 at ANGPT2 promoter), co-immunoprecipitation (MCPH1-DNMT), methylation analysis, MCPH1 knockdown with promoter methylation assay\",\n      \"journal\": \"The FEBS journal\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Weak — ChIP and Co-IP with mechanistic link to promoter methylation, single lab\",\n      \"pmids\": [\"25703238\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"MCPH1 function is required for cellular adaptation to the G2 decatenation checkpoint (bypass of G2 arrest caused by topoisomerase II inhibition), but is dispensable for activation and maintenance of the decatenation checkpoint itself. MCPH1 does not confer adaptation to ATM/ATR-based DNA damage G2 arrest.\",\n      \"method\": \"MCPH1-depleted HeLa cells, topoisomerase II inhibitor (ICRF-193) G2 arrest assay, checkpoint adaptation assay (live imaging of mitotic entry), ATM/ATR inhibitor comparison\",\n      \"journal\": \"FASEB journal : official publication of the Federation of American Societies for Experimental Biology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Weak — functional checkpoint assay with live imaging, single lab, novel role established\",\n      \"pmids\": [\"30964711\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"MCPH1 represses hTERT promoter activity by directly binding to the proximal hTERT promoter as shown by EMSA. Overexpression of MCPH1 reduces telomerase activity, and siRNA knockdown of MCPH1 abolishes this repression.\",\n      \"method\": \"Luciferase reporter assay with hTERT promoter, EMSA (electrophoretic mobility shift assay), siRNA knockdown, telomerase activity assay (TRAP)\",\n      \"journal\": \"Gene\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Weak — EMSA and reporter assay with functional validation, single lab\",\n      \"pmids\": [\"22240313\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"The central domain of MCPH1 (encoded by exon 8) is essential for brain size, gonad development, and prevention of PCC in vivo. Mcph1-Δe8 mice show reduced brain size, thinner cortex, infertility due to germ cell loss, and PCC in MEFs, phenocopying complete Mcph1 knockout.\",\n      \"method\": \"Mouse model with exon 8 deletion (Mcph1-Δe8), brain morphometry, fertility/gonad histology, MEF chromosome condensation assay\",\n      \"journal\": \"Cells\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Weak — in vivo mouse model with functional readouts, but primarily phenotypic characterization without new biochemical interaction data\",\n      \"pmids\": [\"36078123\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"MCPH1 (BRIT1) is a multidomain BRCT-containing protein that functions as: (1) a DNA damage sensor recruited to DSBs via its C-terminal tandem BRCT domains binding γH2AX (both pSer139 and pSer139/pTyr142 states), where it recruits the SWI-SNF chromatin remodeling complex (via ATM/ATR-dependent BAF170 phosphorylation) to relax chromatin and facilitate repair factor access; (2) a regulator of homologous recombination by binding RAD51/BRCA2, stabilizing RAD51-ssDNA filaments, and promoting RAD51/BRCA2 recruitment to damage sites; (3) a negative regulator of Condensin II during interphase via direct binding to the NCAPG2/CAPG2 subunit, preventing premature chromosome condensation; (4) a centrosomal protein whose loss abrogates Chk1 centrosomal localization, causing premature Cdk1 activation and early mitotic entry that shifts neuroprogenitor division from symmetric to asymmetric, thereby causing microcephaly; (5) a regulator of Cdc25A degradation through promotion of βTrCP2 E3 ligase activity, itself subject to APC/C-Cdh1-mediated degradation after mitosis; (6) a transcriptional co-regulator cooperating with E2F1 to drive expression of CHK1, BRCA1, RAD51, and p73; and (7) in hematopoietic stem cells, a cytoplasmic suppressor of necroptosis by binding p-RIPK3, with aging-associated KAT7-mediated NLS acetylation driving its nuclear translocation and consequent necroptosis activation.\"\n}\n```","stage2_raw":"{\n  \"mechanistic_narrative\": \"MCPH1 (BRIT1) is a multidomain BRCT protein that integrates the DNA damage response with chromosome condensation control and cell-cycle timing, and whose loss causes primary microcephaly [#0, #10]. As a proximal DNA damage sensor, MCPH1 forms ionizing-radiation-induced nuclear foci within minutes and is required for activation of intra-S and G2/M checkpoints upstream of BRCA1 and Chk1 [#0, #1]; its C-terminal tandem BRCT domains dock directly onto phospho-H2AX, reading both the pSer139 and pSer139/pTyr142 marks through a distinctive phosphopeptide pocket [#2, #14, #15], while its N-terminal BRCT domain directs centrosomal localization [#3]. Recruitment to breaks is gated by a USP8-catalyzed, BRUCE-scaffolded deubiquitination of K63-linked chains on MCPH1 [#16], after which MCPH1 engages the SWI-SNF complex via BAF170 in an ATM/ATR-dependent manner to relax chromatin and license repair-factor access [#4]. In homologous recombination, MCPH1 binds RAD51/BRCA2 and single-stranded DNA, stabilizing RAD51-ssDNA filaments and promoting RAD51/BRCA2 loading at damage sites [#9, #19]. Independently of damage signaling, MCPH1 is a negative regulator of Condensin II during interphase, binding the NCAPG2/CAPG2 subunit through a short linear motif and using its N-terminal BRCT domain to compete for Condensin II chromosomal binding sites, thereby preventing premature chromosome condensation [#5, #11, #21]; the N-terminal BRCT and central (exon 8) domains are each individually essential for brain size, gonad development, and PCC suppression in vivo [#22, #36]. MCPH1 also controls mitotic timing: it abrogates premature Cdk1 activation by maintaining Chk1 at centrosomes and by promoting βTrCP2-dependent Cdc25A degradation, and its loss switches neuroprogenitor divisions from symmetric to asymmetric to cause microcephaly [#10, #17]. As a transcriptional co-regulator, MCPH1 cooperates with E2F1 to drive CHK1, BRCA1, RAD51, and p73 expression [#6]. A distinct cytoplasmic function maintains hematopoietic stem cells by binding phospho-RIPK3 to suppress necroptosis, an activity lost when aging-associated KAT7-mediated acetylation of the MCPH1 NLS drives nuclear translocation [#28].\",\n  \"teleology\": [\n    {\n      \"year\": 2005,\n      \"claim\": \"Established MCPH1/BRIT1 as a required upstream component of the DNA damage checkpoint, answering whether it has a functional role in the DDR rather than being a passive marker.\",\n      \"evidence\": \"siRNA depletion with checkpoint flow cytometry, Western blot, and γH2AX foci co-localization in human cells\",\n      \"pmids\": [\"16217032\", \"bio_10.1101_2025.06.19.660578\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Did not define the molecular mechanism of recruitment to damage sites\", \"Direct vs. transcriptional contribution to BRCA1/Chk1 reduction unresolved\"]\n    },\n    {\n      \"year\": 2006,\n      \"claim\": \"Positioned BRIT1 as a proximal factor in the ATM/ATR pathway by showing rapid focus formation and co-localization with core DDR mediators, and that its loss increases genomic instability.\",\n      \"evidence\": \"Immunofluorescence foci analysis, co-localization with 53BP1/MDC1/NBS1/ATM/RPA/ATR, and chromosomal aberration assays after siRNA knockdown\",\n      \"pmids\": [\"16872911\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Did not identify the molecular determinant of focus targeting\", \"Order of recruitment relative to MDC1 not yet resolved\"]\n    },\n    {\n      \"year\": 2007,\n      \"claim\": \"Mapped the recruitment mechanism to defined domains, showing the C-terminal tandem BRCT domains bind γH2AX for IRIF formation while the N-terminal BRCT drives centrosomal targeting.\",\n      \"evidence\": \"BRCT domain deletion/mutation constructs, in vitro peptide binding, and immunofluorescence in H2AX-deficient, MDC1-depleted, ATM/Brca1-deficient cells (including DT40)\",\n      \"pmids\": [\"17925396\", \"17599047\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Structural basis of the BRCT-phosphopeptide interaction not yet resolved\", \"Centrosomal binding partner unknown\"]\n    },\n    {\n      \"year\": 2008,\n      \"claim\": \"Defined how MCPH1 acts after recruitment, linking it to chromatin remodeling, HR repair via Condensin II, and E2F1-dependent transcription of DDR genes.\",\n      \"evidence\": \"Co-IP, chromatin fractionation/accessibility assays, domain mapping, DR-GFP HR reporter in null MEFs, and ChIP/reporter assays for E2F1 targets\",\n      \"pmids\": [\"19525936\", \"18718915\", \"18660752\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"How SWI-SNF recruitment, HR, and transcription are temporally coordinated unclear\", \"Whether Condensin II binding and HR are mechanistically separable not addressed\"]\n    },\n    {\n      \"year\": 2010,\n      \"claim\": \"Distinguished MCPH1's anti-condensation activity from its HR role and validated HR function in vivo, establishing Condensin II as the effector of the PCC phenotype.\",\n      \"evidence\": \"Selective Condensin I/II subunit depletion in patient cells; BRIT1 knockout mice with γ-irradiation sensitivity, RAD51 foci, meiotic spreads, and RAD51/BRCA2 Co-IP/chromatin fractionation\",\n      \"pmids\": [\"16434882\", \"20107607\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Biochemical mechanism of RAD51 promotion not yet defined\", \"How MCPH1 distinguishes interphase Condensin II inhibition from repair functions unclear\"]\n    },\n    {\n      \"year\": 2011,\n      \"claim\": \"Resolved the structural and mechanistic basis for Condensin II inhibition and microcephaly, showing N-terminal competition for Condensin II, a SET partner, and a centrosomal Chk1-Cdk1-Cdc25b axis controlling neuroprogenitor division mode.\",\n      \"evidence\": \"Xenopus egg extract reconstitution, crystal structure of N-BRCT with rescue mutagenesis, SET Co-IP/epistasis, and Mcph1-knockout mouse with in vivo Cdc25b rescue\",\n      \"pmids\": [\"21911480\", \"19925808\", \"21515671\", \"21947081\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"How N-BRCT pocket binding to SET relates to Condensin II competition mechanistically unresolved\", \"Direct connection between centrosomal Chk1 loss and division-mode switch incompletely defined\"]\n    },\n    {\n      \"year\": 2011,\n      \"claim\": \"Extended BRCT-phosphopeptide reading beyond γH2AX, showing the C-BRCTs bind phospho-Cdc27 of the APC/C, broadening MCPH1's mitotic interaction repertoire.\",\n      \"evidence\": \"Crystal structure of C-BRCT-pCdc27 peptide complex with in vitro binding and structure-guided mutagenesis\",\n      \"pmids\": [\"22139841\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Functional consequence of MCPH1-pCdc27 binding for APC/C activity not established\"]\n    },\n    {\n      \"year\": 2012,\n      \"claim\": \"Provided structural definition of the C-BRCT phosphopeptide pocket and showed it is distinct from canonical BRCT domains with selectivity for pSer+3 and a free C-terminus.\",\n      \"evidence\": \"X-ray crystallography of C-BRCTs alone and with γH2AX tail, plus fluorescence polarization binding assays\",\n      \"pmids\": [\"22154951\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"In vivo significance of the C-terminal selectivity not directly tested\"]\n    },\n    {\n      \"year\": 2012,\n      \"claim\": \"Demonstrated MCPH1 acts directly on the hTERT promoter to repress telomerase, indicating a sequence-specific transcriptional repressor activity.\",\n      \"evidence\": \"Luciferase reporter, EMSA, siRNA knockdown, and TRAP telomerase activity assay\",\n      \"pmids\": [\"22240313\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Single lab; direct DNA-binding mode not structurally defined\", \"Cofactors required for repression unidentified\"]\n    },\n    {\n      \"year\": 2013,\n      \"claim\": \"Connected MCPH1 loss to a specific neurodevelopmental defect, showing premature neurogenesis skews cortical layer composition without affecting migration.\",\n      \"evidence\": \"Mcph1 knockout mouse with BrdU/EdU cortical layer birth-dating, HR assays, and TUNEL after irradiation\",\n      \"pmids\": [\"23683352\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Relative contribution of HR defects vs. mitotic timing to the layering phenotype unresolved\"]\n    },\n    {\n      \"year\": 2014,\n      \"claim\": \"Identified additional regulatory roles in p53 stabilization and ATR signaling amplification, linking MCPH1 to tumor suppression and replication-stress responses.\",\n      \"evidence\": \"Co-IP (MDM2/p53; TopBP1), ubiquitination assays, pSer-322 phospho-antibody, transformation and xenograft assays\",\n      \"pmids\": [\"23729656\", \"25301947\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"TopBP1 recruitment role not independently replicated\", \"Mechanism by which MCPH1 blocks MDM2-mediated p53 ubiquitination not structurally defined\"]\n    },\n    {\n      \"year\": 2015,\n      \"claim\": \"Defined the upstream gate for MCPH1 recruitment and additional roles in centrosome and gene-silencing control, showing K63-deubiquitination via BRUCE/USP8 is a prerequisite for γH2AX binding.\",\n      \"evidence\": \"K63-ubiquitination assays, trimeric BRUCE-USP8-BRIT1 Co-IP, UBC domain mutants, BRUCE mutant mice, plus centrosome STIL/CDK2 and ANGPT2 promoter methylation studies\",\n      \"pmids\": [\"25733871\", \"26683461\", \"32681070\", \"25703238\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"STIL/CDK2 and ANGPT2 mechanisms from single labs\", \"How deubiquitination is timed relative to break formation unclear\"]\n    },\n    {\n      \"year\": 2017,\n      \"claim\": \"Established MCPH1 as both a regulator and substrate of cell-cycle proteolysis, promoting βTrCP2-dependent Cdc25A degradation while itself being degraded by APC/C-Cdh1, and validated a role in immunoglobulin class switch recombination.\",\n      \"evidence\": \"Co-IP, degradation assays, in utero electroporation rescue (βTrCP2/Cdc25A), conditional B-cell knockout with Igh ChIP and CSR assays\",\n      \"pmids\": [\"29150431\", \"28724724\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"How the Cdc25A and centrosomal Chk1 axes integrate not fully resolved\", \"CSR role mechanism relative to MDC1 redundancy incompletely mapped\"]\n    },\n    {\n      \"year\": 2018,\n      \"claim\": \"Refined the proteolytic control of MCPH1 by showing isoform-specific APC/C-Cdh1 degradation via distinct D-box and KEN-box degrons after mitotic exit.\",\n      \"evidence\": \"Cell-cycle synchronization, phospho-site identification, APC/C Co-IP, and degron mutagenesis\",\n      \"pmids\": [\"30303738\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Single lab; functional consequence of isoform-specific turnover not established\"]\n    },\n    {\n      \"year\": 2019,\n      \"claim\": \"Identified a selective role in decatenation checkpoint adaptation, distinct from ATM/ATR DNA-damage checkpoint control.\",\n      \"evidence\": \"MCPH1-depleted HeLa cells with ICRF-193 G2 arrest and live-imaging adaptation assays versus ATM/ATR inhibitors\",\n      \"pmids\": [\"30964711\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Single lab; molecular mechanism of adaptation not defined\"]\n    },\n    {\n      \"year\": 2020,\n      \"claim\": \"Provided direct biochemical and structural mechanisms for HR and telomere functions, showing MCPH1 stabilizes RAD51-ssDNA filaments and is recruited to telomeres via TRF2 to promote fork progression.\",\n      \"evidence\": \"Purified-protein reconstitution with single-molecule TPM, RAD51 interaction mapping, crystal structure of MCPH1-TRF2, and telomere TIF/DNA fiber assays\",\n      \"pmids\": [\"32735676\", \"33203878\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether filament stabilization fully accounts for in vivo HR phenotypes not established\", \"Mitochondrial localization role (idx 27) remains correlative\"]\n    },\n    {\n      \"year\": 2021,\n      \"claim\": \"Established MCPH1 as a constitutive interphase brake on Condensin II analogous to WAPL on cohesin, binding NCAPG2 and preventing CDK1-independent chromosome compaction, and assigned domain-specific essentiality in vivo.\",\n      \"evidence\": \"Mcph1 knockout ESC Hi-C, CDK1 inhibition, SMC2-NCAPH2 fusion epistasis, Co-IP, and Mcph1-ΔBR1 mouse phenotyping\",\n      \"pmids\": [\"34850681\", \"33542216\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Structural basis of the NCAPG2 short-linear-motif interaction not resolved\", \"How interphase Condensin II inhibition is relieved at mitotic onset unclear\"]\n    },\n    {\n      \"year\": 2024,\n      \"claim\": \"Revealed a non-nuclear function in hematopoietic stem cells, where cytoplasmic MCPH1 suppresses necroptosis and aging-driven KAT7 acetylation of its NLS redistributes it to the nucleus.\",\n      \"evidence\": \"Subcellular fractionation, MCPH1-p-RIPK3 Co-IP, acetylation mapping, KAT7 inhibition, NLS mutagenesis, and HSC transplantation assays\",\n      \"pmids\": [\"38632351\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether cytoplasmic anti-necroptotic function operates in other cell types unknown\", \"Structural basis of MCPH1-RIPK3 binding undefined\"]\n    },\n    {\n      \"year\": 2024,\n      \"claim\": \"Clarified that p53/p19ARF activation in Mcph1-deficient cells is a consequence rather than a cause of the proliferation defect, refining the senescence and anemia phenotype interpretation.\",\n      \"evidence\": \"Mcph1 knockout mouse/MEF RNA-seq, p19Arf siRNA rescue, and Mcph1/p53 double-knockout epistasis\",\n      \"pmids\": [\"38731817\", \"38605277\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Primary lesion upstream of p19ARF activation not pinpointed\", \"Single-lab characterization\"]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"How MCPH1's distinct activities — γH2AX-dependent DDR recruitment, RAD51 filament stabilization, interphase Condensin II inhibition, centrosomal Chk1/Cdc25A timing, and cytoplasmic necroptosis suppression — are coordinated within a single cell and which is rate-limiting for microcephaly remains unresolved.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"High\",\n      \"gaps\": [\"No unified model integrating nuclear DDR/condensation and cytoplasmic functions\", \"Domain-level determinants of partner selection among γH2AX, NCAPG2, RAD51, and RIPK3 not jointly mapped\"]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0003677\", \"supporting_discovery_ids\": [19, 35, 33]},\n      {\"term_id\": \"GO:0140110\", \"supporting_discovery_ids\": [6, 35, 33]},\n      {\"term_id\": \"GO:0098772\", \"supporting_discovery_ids\": [5, 11, 21, 24, 17]},\n      {\"term_id\": \"GO:0042393\", \"supporting_discovery_ids\": [2, 14, 15]},\n      {\"term_id\": \"GO:0060090\", \"supporting_discovery_ids\": [4, 16]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005634\", \"supporting_discovery_ids\": [1, 2, 28]},\n      {\"term_id\": \"GO:0000228\", \"supporting_discovery_ids\": [1, 2, 3]},\n      {\"term_id\": \"GO:0005815\", \"supporting_discovery_ids\": [3, 10, 32]},\n      {\"term_id\": \"GO:0005829\", \"supporting_discovery_ids\": [28]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-73894\", \"supporting_discovery_ids\": [0, 1, 4, 9, 19]},\n      {\"term_id\": \"R-HSA-1640170\", \"supporting_discovery_ids\": [10, 17, 34]},\n      {\"term_id\": \"R-HSA-4839726\", \"supporting_discovery_ids\": [4, 21]},\n      {\"term_id\": \"R-HSA-74160\", \"supporting_discovery_ids\": [6, 33, 35]},\n      {\"term_id\": \"R-HSA-1266738\", \"supporting_discovery_ids\": [10, 23]},\n      {\"term_id\": \"R-HSA-5357801\", \"supporting_discovery_ids\": [28]}\n    ],\n    \"complexes\": [\"SWI-SNF (via BAF170)\", \"BRUCE-USP8-BRIT1 deubiquitination complex\"],\n    \"partners\": [\"H2AX\", \"RAD51\", \"BRCA2\", \"NCAPG2/CAPG2\", \"E2F1\", \"TRF2\", \"USP8\", \"RIPK3\"],\n    \"other_free_text\": []\n  }\n}","audit_flag":null,"evaluation":{"pairwise":"win","faith_supported":8,"faith_total":8,"faith_pct":100.0}}